id	sid	tid	token	lemma	pos
ajbspi-37611	1	1	volume	volume	NOUN
ajbspi-37611	1	2	03	03	NUM
ajbspi-37611	1	3	issue	issue	NOUN
ajbspi-37611	1	4	10	10	NUM
ajbspi-37611	1	5	-	-	SYM
ajbspi-37611	1	6	2023	2023	NUM
ajbspi-37611	1	7	1	1	NUM
ajbspi-37611	1	8	american	american	ADJ
ajbspi-37611	1	9	journal	journal	NOUN
ajbspi-37611	1	10	of	of	ADP
ajbspi-37611	1	11	biomedical	biomedical	PROPN
ajbspi-37611	1	12	science	science	PROPN
ajbspi-37611	1	13	&	&	CCONJ
ajbspi-37611	1	14	pharmaceutical	pharmaceutical	PROPN
ajbspi-37611	1	15	innovation	innovation	NOUN
ajbspi-37611	1	16	(	(	PUNCT
ajbspi-37611	1	17	issn	issn	PROPN
ajbspi-37611	1	18	–	–	PUNCT
ajbspi-37611	1	19	2771	2771	NUM
ajbspi-37611	1	20	-	-	SYM
ajbspi-37611	1	21	2753	2753	NUM
ajbspi-37611	1	22	)	)	PUNCT
ajbspi-37611	1	23	volume	volume	NOUN
ajbspi-37611	1	24	03	03	NUM
ajbspi-37611	1	25	issue	issue	NOUN
ajbspi-37611	1	26	10	10	NUM
ajbspi-37611	1	27	pages	page	NOUN
ajbspi-37611	1	28	:	:	PUNCT
ajbspi-37611	1	29	1	1	NUM
ajbspi-37611	1	30	-	-	SYM
ajbspi-37611	1	31	5	5	NUM
ajbspi-37611	1	32	sjif	sjif	NOUN
ajbspi-37611	1	33	impact	impact	NOUN
ajbspi-37611	1	34	factor	factor	NOUN
ajbspi-37611	1	35	(	(	PUNCT
ajbspi-37611	1	36	2021	2021	NUM
ajbspi-37611	1	37	:	:	PUNCT
ajbspi-37611	1	38	5	5	NUM
ajbspi-37611	1	39	.	.	NOUN
ajbspi-37611	1	40	705	705	NUM
ajbspi-37611	1	41	)	)	PUNCT
ajbspi-37611	1	42	(	(	PUNCT
ajbspi-37611	1	43	2022	2022	NUM
ajbspi-37611	1	44	:	:	PUNCT
ajbspi-37611	1	45	5	5	NUM
ajbspi-37611	1	46	.	.	NOUN
ajbspi-37611	1	47	705	705	NUM
ajbspi-37611	1	48	)	)	PUNCT
ajbspi-37611	1	49	(	(	PUNCT
ajbspi-37611	1	50	2023	2023	NUM
ajbspi-37611	1	51	:	:	PUNCT
ajbspi-37611	1	52	6.534	6.534	NUM
ajbspi-37611	1	53	)	)	PUNCT
ajbspi-37611	1	54	oclc	oclc	PROPN
ajbspi-37611	1	55	–	–	PUNCT
ajbspi-37611	1	56	1121105677	1121105677	NUM
ajbspi-37611	1	57	publisher	publisher	NOUN
ajbspi-37611	1	58	:	:	PUNCT
ajbspi-37611	1	59	oscar	oscar	NOUN
ajbspi-37611	1	60	publishing	publishing	NOUN
ajbspi-37611	1	61	services	service	NOUN
ajbspi-37611	1	62	servi	servi	PROPN
ajbspi-37611	1	63	abstract	abstract	ADV
ajbspi-37611	1	64	this	this	DET
ajbspi-37611	1	65	comprehensive	comprehensive	ADJ
ajbspi-37611	1	66	review	review	NOUN
ajbspi-37611	1	67	delves	delve	VERB
ajbspi-37611	1	68	into	into	ADP
ajbspi-37611	1	69	the	the	DET
ajbspi-37611	1	70	cutting	cutting	NOUN
ajbspi-37611	1	71	-	-	PUNCT
ajbspi-37611	1	72	edge	edge	NOUN
ajbspi-37611	1	73	advancements	advancement	NOUN
ajbspi-37611	1	74	in	in	ADP
ajbspi-37611	1	75	the	the	DET
ajbspi-37611	1	76	treatment	treatment	NOUN
ajbspi-37611	1	77	landscape	landscape	NOUN
ajbspi-37611	1	78	of	of	ADP
ajbspi-37611	1	79	advanced	advanced	ADJ
ajbspi-37611	1	80	ovarian	ovarian	ADJ
ajbspi-37611	1	81	cancer	cancer	NOUN
ajbspi-37611	1	82	,	,	PUNCT
ajbspi-37611	1	83	with	with	ADP
ajbspi-37611	1	84	a	a	DET
ajbspi-37611	1	85	specific	specific	ADJ
ajbspi-37611	1	86	focus	focus	NOUN
ajbspi-37611	1	87	on	on	ADP
ajbspi-37611	1	88	the	the	DET
ajbspi-37611	1	89	programmed	program	VERB
ajbspi-37611	1	90	cell	cell	NOUN
ajbspi-37611	1	91	death	death	NOUN
ajbspi-37611	1	92	protein	protein	NOUN
ajbspi-37611	1	93	1	1	NUM
ajbspi-37611	1	94	(	(	PUNCT
ajbspi-37611	1	95	pd-1	pd-1	ADV
ajbspi-37611	1	96	)	)	PUNCT
ajbspi-37611	1	97	and	and	CCONJ
ajbspi-37611	1	98	its	its	PRON
ajbspi-37611	1	99	ligand	ligand	ADJ
ajbspi-37611	1	100	pd	pd	PROPN
ajbspi-37611	1	101	-	-	PROPN
ajbspi-37611	1	102	l1	l1	PROPN
ajbspi-37611	1	103	pathway	pathway	NOUN
ajbspi-37611	1	104	.	.	PUNCT
ajbspi-37611	2	1	ovarian	ovarian	ADJ
ajbspi-37611	2	2	cancer	cancer	NOUN
ajbspi-37611	2	3	,	,	PUNCT
ajbspi-37611	2	4	often	often	ADV
ajbspi-37611	2	5	diagnosed	diagnose	VERB
ajbspi-37611	2	6	at	at	ADP
ajbspi-37611	2	7	advanced	advanced	ADJ
ajbspi-37611	2	8	stages	stage	NOUN
ajbspi-37611	2	9	,	,	PUNCT
ajbspi-37611	2	10	poses	pose	VERB
ajbspi-37611	2	11	significant	significant	ADJ
ajbspi-37611	2	12	challenges	challenge	NOUN
ajbspi-37611	2	13	due	due	ADJ
ajbspi-37611	2	14	to	to	ADP
ajbspi-37611	2	15	limited	limited	ADJ
ajbspi-37611	2	16	effective	effective	ADJ
ajbspi-37611	2	17	treatment	treatment	NOUN
ajbspi-37611	2	18	options	option	NOUN
ajbspi-37611	2	19	.	.	PUNCT
ajbspi-37611	3	1	the	the	DET
ajbspi-37611	3	2	emergence	emergence	NOUN
ajbspi-37611	3	3	of	of	ADP
ajbspi-37611	3	4	immune	immune	ADJ
ajbspi-37611	3	5	checkpoint	checkpoint	NOUN
ajbspi-37611	3	6	inhibitors	inhibitor	NOUN
ajbspi-37611	3	7	targeting	target	VERB
ajbspi-37611	3	8	the	the	DET
ajbspi-37611	3	9	pd-1	pd-1	NOUN
ajbspi-37611	3	10	/	/	SYM
ajbspi-37611	3	11	pd	pd	ADJ
ajbspi-37611	3	12	-	-	PUNCT
ajbspi-37611	3	13	l1	l1	PROPN
ajbspi-37611	3	14	pathway	pathway	NOUN
ajbspi-37611	3	15	has	have	AUX
ajbspi-37611	3	16	sparked	spark	VERB
ajbspi-37611	3	17	new	new	ADJ
ajbspi-37611	3	18	hope	hope	NOUN
ajbspi-37611	3	19	for	for	ADP
ajbspi-37611	3	20	improved	improved	ADJ
ajbspi-37611	3	21	outcomes	outcome	NOUN
ajbspi-37611	3	22	.	.	PUNCT
ajbspi-37611	4	1	this	this	DET
ajbspi-37611	4	2	review	review	NOUN
ajbspi-37611	4	3	explores	explore	VERB
ajbspi-37611	4	4	the	the	DET
ajbspi-37611	4	5	mechanistic	mechanistic	ADJ
ajbspi-37611	4	6	basis	basis	NOUN
ajbspi-37611	4	7	of	of	ADP
ajbspi-37611	4	8	pd-1	pd-1	ADP
ajbspi-37611	4	9	/	/	SYM
ajbspi-37611	4	10	pd	pd	ADJ
ajbspi-37611	4	11	-	-	PUNCT
ajbspi-37611	4	12	l1	l1	PROPN
ajbspi-37611	4	13	interactions	interaction	NOUN
ajbspi-37611	4	14	,	,	PUNCT
ajbspi-37611	4	15	outlines	outline	VERB
ajbspi-37611	4	16	the	the	DET
ajbspi-37611	4	17	evolving	evolve	VERB
ajbspi-37611	4	18	clinical	clinical	ADJ
ajbspi-37611	4	19	trials	trial	NOUN
ajbspi-37611	4	20	assessing	assess	VERB
ajbspi-37611	4	21	immune	immune	ADJ
ajbspi-37611	4	22	checkpoint	checkpoint	NOUN
ajbspi-37611	4	23	inhibitors	inhibitor	NOUN
ajbspi-37611	4	24	,	,	PUNCT
ajbspi-37611	4	25	and	and	CCONJ
ajbspi-37611	4	26	discusses	discuss	VERB
ajbspi-37611	4	27	the	the	DET
ajbspi-37611	4	28	clinical	clinical	ADJ
ajbspi-37611	4	29	significance	significance	NOUN
ajbspi-37611	4	30	of	of	ADP
ajbspi-37611	4	31	these	these	DET
ajbspi-37611	4	32	therapies	therapy	NOUN
ajbspi-37611	4	33	in	in	ADP
ajbspi-37611	4	34	reshaping	reshape	VERB
ajbspi-37611	4	35	the	the	DET
ajbspi-37611	4	36	therapeutic	therapeutic	ADJ
ajbspi-37611	4	37	paradigm	paradigm	NOUN
ajbspi-37611	4	38	for	for	ADP
ajbspi-37611	4	39	advanced	advanced	ADJ
ajbspi-37611	4	40	ovarian	ovarian	ADJ
ajbspi-37611	4	41	cancer	cancer	NOUN
ajbspi-37611	4	42	.	.	PUNCT
ajbspi-37611	5	1	keywords	keyword	NOUN
ajbspi-37611	5	2	advanced	advanced	ADJ
ajbspi-37611	5	3	ovarian	ovarian	ADJ
ajbspi-37611	5	4	cancer	cancer	NOUN
ajbspi-37611	5	5	,	,	PUNCT
ajbspi-37611	5	6	immune	immune	ADJ
ajbspi-37611	5	7	checkpoint	checkpoint	NOUN
ajbspi-37611	5	8	inhibitors	inhibitor	NOUN
ajbspi-37611	5	9	,	,	PUNCT
ajbspi-37611	5	10	pd-1	pd-1	NOUN
ajbspi-37611	5	11	/	/	SYM
ajbspi-37611	5	12	pd	pd	ADJ
ajbspi-37611	5	13	-	-	PROPN
ajbspi-37611	5	14	l1	l1	PROPN
ajbspi-37611	5	15	pathway	pathway	NOUN
ajbspi-37611	5	16	,	,	PUNCT
ajbspi-37611	5	17	programmed	program	VERB
ajbspi-37611	5	18	cell	cell	NOUN
ajbspi-37611	5	19	death	death	NOUN
ajbspi-37611	5	20	protein	protein	NOUN
ajbspi-37611	5	21	1	1	NUM
ajbspi-37611	5	22	,	,	PUNCT
ajbspi-37611	5	23	pd	pd	PROPN
ajbspi-37611	5	24	-	-	PUNCT
ajbspi-37611	5	25	l1	l1	PROPN
ajbspi-37611	5	26	ligand	ligand	NOUN
ajbspi-37611	5	27	,	,	PUNCT
ajbspi-37611	5	28	immunotherapy	immunotherapy	NOUN
ajbspi-37611	5	29	,	,	PUNCT
ajbspi-37611	5	30	treatment	treatment	NOUN
ajbspi-37611	5	31	advancements	advancement	NOUN
ajbspi-37611	5	32	,	,	PUNCT
ajbspi-37611	5	33	clinical	clinical	ADJ
ajbspi-37611	5	34	trials	trial	NOUN
ajbspi-37611	5	35	,	,	PUNCT
ajbspi-37611	5	36	therapeutic	therapeutic	ADJ
ajbspi-37611	5	37	paradigm	paradigm	NOUN
ajbspi-37611	5	38	,	,	PUNCT
ajbspi-37611	5	39	oncology	oncology	NOUN
ajbspi-37611	5	40	.	.	PUNCT
ajbspi-37611	6	1	introduction	introduction	NOUN
ajbspi-37611	6	2	advanced	advanced	ADJ
ajbspi-37611	6	3	ovarian	ovarian	ADJ
ajbspi-37611	6	4	cancer	cancer	NOUN
ajbspi-37611	6	5	remains	remain	VERB
ajbspi-37611	6	6	a	a	DET
ajbspi-37611	6	7	formidable	formidable	ADJ
ajbspi-37611	6	8	challenge	challenge	NOUN
ajbspi-37611	6	9	in	in	ADP
ajbspi-37611	6	10	the	the	DET
ajbspi-37611	6	11	field	field	NOUN
ajbspi-37611	6	12	of	of	ADP
ajbspi-37611	6	13	oncology	oncology	NOUN
ajbspi-37611	6	14	,	,	PUNCT
ajbspi-37611	6	15	often	often	ADV
ajbspi-37611	6	16	diagnosed	diagnose	VERB
ajbspi-37611	6	17	at	at	ADP
ajbspi-37611	6	18	stages	stage	NOUN
ajbspi-37611	6	19	where	where	SCONJ
ajbspi-37611	6	20	effective	effective	ADJ
ajbspi-37611	6	21	treatment	treatment	NOUN
ajbspi-37611	6	22	options	option	NOUN
ajbspi-37611	6	23	are	be	AUX
ajbspi-37611	6	24	limited	limit	VERB
ajbspi-37611	6	25	,	,	PUNCT
ajbspi-37611	6	26	leading	lead	VERB
ajbspi-37611	6	27	to	to	ADP
ajbspi-37611	6	28	a	a	DET
ajbspi-37611	6	29	pressing	press	VERB
ajbspi-37611	6	30	need	need	NOUN
ajbspi-37611	6	31	for	for	ADP
ajbspi-37611	6	32	innovative	innovative	ADJ
ajbspi-37611	6	33	therapeutic	therapeutic	ADJ
ajbspi-37611	6	34	strategies	strategy	NOUN
ajbspi-37611	6	35	.	.	PUNCT
ajbspi-37611	7	1	the	the	DET
ajbspi-37611	7	2	programmed	program	VERB
ajbspi-37611	7	3	cell	cell	NOUN
ajbspi-37611	7	4	death	death	NOUN
ajbspi-37611	7	5	protein	protein	NOUN
ajbspi-37611	7	6	1	1	NUM
ajbspi-37611	7	7	(	(	PUNCT
ajbspi-37611	7	8	pd-1	pd-1	ADV
ajbspi-37611	7	9	)	)	PUNCT
ajbspi-37611	7	10	and	and	CCONJ
ajbspi-37611	7	11	its	its	PRON
ajbspi-37611	7	12	ligand	ligand	ADJ
ajbspi-37611	7	13	pd	pd	PROPN
ajbspi-37611	7	14	-	-	PROPN
ajbspi-37611	7	15	l1	l1	PROPN
ajbspi-37611	7	16	pathway	pathway	NOUN
ajbspi-37611	7	17	,	,	PUNCT
ajbspi-37611	7	18	critical	critical	ADJ
ajbspi-37611	7	19	in	in	ADP
ajbspi-37611	7	20	immune	immune	ADJ
ajbspi-37611	7	21	research	research	NOUN
ajbspi-37611	7	22	article	article	NOUN
ajbspi-37611	7	23	revolutionizing	revolutionize	VERB
ajbspi-37611	7	24	advanced	advanced	ADJ
ajbspi-37611	7	25	ovarian	ovarian	ADJ
ajbspi-37611	7	26	cancer	cancer	NOUN
ajbspi-37611	7	27	therapy	therapy	NOUN
ajbspi-37611	7	28	:	:	PUNCT
ajbspi-37611	7	29	a	a	DET
ajbspi-37611	7	30	focus	focus	NOUN
ajbspi-37611	7	31	on	on	ADP
ajbspi-37611	7	32	the	the	DET
ajbspi-37611	7	33	pd1	pd1	NOUN
ajbspi-37611	7	34	/	/	SYM
ajbspi-37611	7	35	pd	pd	NOUN
ajbspi-37611	7	36	-	-	PUNCT
ajbspi-37611	7	37	l1	l1	PROPN
ajbspi-37611	7	38	pathway	pathway	NOUN
ajbspi-37611	7	39	submission	submission	NOUN
ajbspi-37611	7	40	date	date	NOUN
ajbspi-37611	7	41	:	:	PUNCT
ajbspi-37611	7	42	sep	sep	PROPN
ajbspi-37611	7	43	21	21	NUM
ajbspi-37611	7	44	,	,	PUNCT
ajbspi-37611	7	45	2023	2023	NUM
ajbspi-37611	7	46	,	,	PUNCT
ajbspi-37611	7	47	accepted	accept	VERB
ajbspi-37611	7	48	date	date	NOUN
ajbspi-37611	7	49	:	:	PUNCT
ajbspi-37611	7	50	sep	sep	PROPN
ajbspi-37611	7	51	26	26	NUM
ajbspi-37611	7	52	,	,	PUNCT
ajbspi-37611	7	53	2023	2023	NUM
ajbspi-37611	7	54	,	,	PUNCT
ajbspi-37611	7	55	published	publish	VERB
ajbspi-37611	7	56	date	date	NOUN
ajbspi-37611	7	57	:	:	PUNCT
ajbspi-37611	7	58	oct	oct	PROPN
ajbspi-37611	7	59	01	01	NUM
ajbspi-37611	7	60	,	,	PUNCT
ajbspi-37611	7	61	2023	2023	NUM
ajbspi-37611	7	62	crossref	crossref	PROPN
ajbspi-37611	7	63	doi	doi	NOUN
ajbspi-37611	7	64	:	:	PUNCT
ajbspi-37611	7	65	https://doi.org/10.37547/ajbspi/volume03issue10-01	https://doi.org/10.37547/ajbspi/volume03issue10-01	PROPN
ajbspi-37611	7	66	mandeep	mandeep	PROPN
ajbspi-37611	7	67	kaur	kaur	PROPN
ajbspi-37611	7	68	consultant	consultant	PROPN
ajbspi-37611	7	69	neurologist	neurologist	NOUN
ajbspi-37611	7	70	,	,	PUNCT
ajbspi-37611	7	71	centre	centre	NOUN
ajbspi-37611	7	72	for	for	ADP
ajbspi-37611	7	73	human	human	ADJ
ajbspi-37611	7	74	reproduction	reproduction	NOUN
ajbspi-37611	7	75	,	,	PUNCT
ajbspi-37611	7	76	india	india	PROPN
ajbspi-37611	7	77	journal	journal	PROPN
ajbspi-37611	7	78	website	website	NOUN
ajbspi-37611	7	79	:	:	PUNCT
ajbspi-37611	7	80	https://theusajournals	https://theusajournals	PROPN
ajbspi-37611	7	81	.	.	PUNCT
ajbspi-37611	7	82	com	com	NOUN
ajbspi-37611	7	83	/	/	SYM
ajbspi-37611	7	84	index.php	index.php	VERB
ajbspi-37611	7	85	/	/	SYM
ajbspi-37611	7	86	ajbspi	ajbspi	NOUN
ajbspi-37611	7	87	copyright	copyright	NOUN
ajbspi-37611	7	88	:	:	PUNCT
ajbspi-37611	7	89	original	original	ADJ
ajbspi-37611	7	90	content	content	NOUN
ajbspi-37611	7	91	from	from	ADP
ajbspi-37611	7	92	this	this	DET
ajbspi-37611	7	93	work	work	NOUN
ajbspi-37611	7	94	may	may	AUX
ajbspi-37611	7	95	be	be	AUX
ajbspi-37611	7	96	used	use	VERB
ajbspi-37611	7	97	under	under	ADP
ajbspi-37611	7	98	the	the	DET
ajbspi-37611	7	99	terms	term	NOUN
ajbspi-37611	7	100	of	of	ADP
ajbspi-37611	7	101	the	the	DET
ajbspi-37611	7	102	creative	creative	ADJ
ajbspi-37611	7	103	commons	common	NOUN
ajbspi-37611	7	104	attributes	attribute	VERB
ajbspi-37611	7	105	4.0	4.0	NUM
ajbspi-37611	7	106	licence	licence	NOUN
ajbspi-37611	7	107	.	.	PUNCT
ajbspi-37611	8	1	https://doi.org/10.37547/ajbspi/volume03issue03-01	https://doi.org/10.37547/ajbspi/volume03issue03-01	PROPN
ajbspi-37611	8	2	https://scholar.google.co.in/scholar?q=	https://scholar.google.co.in/scholar?q=	PROPN
ajbspi-37611	8	3	https://www.mendeley.com/search/?page=1&query=	https://www.mendeley.com/search/?page=1&query=	VERB
ajbspi-37611	8	4	https://theusajournals.com/	https://theusajournals.com/	ADJ
ajbspi-37611	8	5	https://doi.org/10.37547/ajbspi/volume03issue10-01	https://doi.org/10.37547/ajbspi/volume03issue10-01	NOUN
ajbspi-37611	8	6	https://doi.org/10.37547/ajbspi/volume03issue10-01	https://doi.org/10.37547/ajbspi/volume03issue10-01	NOUN
ajbspi-37611	8	7	https://theusajournals.com/index.php/ajbspi	https://theusajournals.com/index.php/ajbspi	NOUN
ajbspi-37611	8	8	https://theusajournals.com/index.php/ajbspi	https://theusajournals.com/index.php/ajbspi	NOUN
ajbspi-37611	8	9	https://theusajournals.com/index.php/ajbspi	https://theusajournals.com/index.php/ajbspi	NOUN
ajbspi-37611	8	10	https://theusajournals.com/index.php/ajbspi	https://theusajournals.com/index.php/ajbspi	NOUN
ajbspi-37611	8	11	volume	volume	NOUN
ajbspi-37611	8	12	03	03	NUM
ajbspi-37611	8	13	issue	issue	NOUN
ajbspi-37611	8	14	10	10	NUM
ajbspi-37611	8	15	-	-	SYM
ajbspi-37611	8	16	2023	2023	NUM
ajbspi-37611	8	17	2	2	NUM
ajbspi-37611	8	18	american	american	ADJ
ajbspi-37611	8	19	journal	journal	NOUN
ajbspi-37611	8	20	of	of	ADP
ajbspi-37611	8	21	biomedical	biomedical	PROPN
ajbspi-37611	8	22	science	science	PROPN
ajbspi-37611	8	23	&	&	CCONJ
ajbspi-37611	8	24	pharmaceutical	pharmaceutical	PROPN
ajbspi-37611	8	25	innovation	innovation	NOUN
ajbspi-37611	8	26	(	(	PUNCT
ajbspi-37611	8	27	issn	issn	PROPN
ajbspi-37611	8	28	–	–	PUNCT
ajbspi-37611	8	29	2771	2771	NUM
ajbspi-37611	8	30	-	-	SYM
ajbspi-37611	8	31	2753	2753	NUM
ajbspi-37611	8	32	)	)	PUNCT
ajbspi-37611	8	33	volume	volume	NOUN
ajbspi-37611	8	34	03	03	NUM
ajbspi-37611	8	35	issue	issue	NOUN
ajbspi-37611	8	36	10	10	NUM
ajbspi-37611	8	37	pages	page	NOUN
ajbspi-37611	8	38	:	:	PUNCT
ajbspi-37611	8	39	1	1	NUM
ajbspi-37611	8	40	-	-	SYM
ajbspi-37611	8	41	5	5	NUM
ajbspi-37611	8	42	sjif	sjif	NOUN
ajbspi-37611	8	43	impact	impact	NOUN
ajbspi-37611	8	44	factor	factor	NOUN
ajbspi-37611	8	45	(	(	PUNCT
ajbspi-37611	8	46	2021	2021	NUM
ajbspi-37611	8	47	:	:	PUNCT
ajbspi-37611	8	48	5	5	NUM
ajbspi-37611	8	49	.	.	NOUN
ajbspi-37611	8	50	705	705	NUM
ajbspi-37611	8	51	)	)	PUNCT
ajbspi-37611	8	52	(	(	PUNCT
ajbspi-37611	8	53	2022	2022	NUM
ajbspi-37611	8	54	:	:	PUNCT
ajbspi-37611	8	55	5	5	NUM
ajbspi-37611	8	56	.	.	NOUN
ajbspi-37611	8	57	705	705	NUM
ajbspi-37611	8	58	)	)	PUNCT
ajbspi-37611	8	59	(	(	PUNCT
ajbspi-37611	8	60	2023	2023	NUM
ajbspi-37611	8	61	:	:	PUNCT
ajbspi-37611	8	62	6.534	6.534	NUM
ajbspi-37611	8	63	)	)	PUNCT
ajbspi-37611	8	64	oclc	oclc	PROPN
ajbspi-37611	8	65	–	–	PUNCT
ajbspi-37611	8	66	1121105677	1121105677	NUM
ajbspi-37611	8	67	publisher	publisher	NOUN
ajbspi-37611	8	68	:	:	PUNCT
ajbspi-37611	8	69	oscar	oscar	NOUN
ajbspi-37611	8	70	publishing	publishing	NOUN
ajbspi-37611	8	71	services	service	NOUN
ajbspi-37611	8	72	servi	servi	PROPN
ajbspi-37611	8	73	regulation	regulation	PROPN
ajbspi-37611	8	74	,	,	PUNCT
ajbspi-37611	8	75	have	have	AUX
ajbspi-37611	8	76	emerged	emerge	VERB
ajbspi-37611	8	77	as	as	ADP
ajbspi-37611	8	78	pivotal	pivotal	ADJ
ajbspi-37611	8	79	targets	target	NOUN
ajbspi-37611	8	80	in	in	ADP
ajbspi-37611	8	81	cancer	cancer	NOUN
ajbspi-37611	8	82	therapy	therapy	NOUN
ajbspi-37611	8	83	.	.	PUNCT
ajbspi-37611	9	1	immune	immune	ADJ
ajbspi-37611	9	2	checkpoint	checkpoint	NOUN
ajbspi-37611	9	3	inhibitors	inhibitor	NOUN
ajbspi-37611	9	4	targeting	target	VERB
ajbspi-37611	9	5	the	the	DET
ajbspi-37611	9	6	pd-1	pd-1	NOUN
ajbspi-37611	9	7	/	/	SYM
ajbspi-37611	9	8	pd	pd	ADJ
ajbspi-37611	9	9	-	-	PUNCT
ajbspi-37611	9	10	l1	l1	PROPN
ajbspi-37611	9	11	pathway	pathway	NOUN
ajbspi-37611	9	12	have	have	AUX
ajbspi-37611	9	13	demonstrated	demonstrate	VERB
ajbspi-37611	9	14	remarkable	remarkable	ADJ
ajbspi-37611	9	15	success	success	NOUN
ajbspi-37611	9	16	in	in	ADP
ajbspi-37611	9	17	diverse	diverse	ADJ
ajbspi-37611	9	18	malignancies	malignancy	NOUN
ajbspi-37611	9	19	,	,	PUNCT
ajbspi-37611	9	20	raising	raise	VERB
ajbspi-37611	9	21	optimism	optimism	NOUN
ajbspi-37611	9	22	for	for	ADP
ajbspi-37611	9	23	their	their	PRON
ajbspi-37611	9	24	potential	potential	NOUN
ajbspi-37611	9	25	in	in	ADP
ajbspi-37611	9	26	transforming	transform	VERB
ajbspi-37611	9	27	the	the	DET
ajbspi-37611	9	28	therapeutic	therapeutic	ADJ
ajbspi-37611	9	29	landscape	landscape	NOUN
ajbspi-37611	9	30	of	of	ADP
ajbspi-37611	9	31	advanced	advanced	ADJ
ajbspi-37611	9	32	ovarian	ovarian	ADJ
ajbspi-37611	9	33	cancer	cancer	NOUN
ajbspi-37611	9	34	.	.	PUNCT
ajbspi-37611	10	1	this	this	DET
ajbspi-37611	10	2	review	review	NOUN
ajbspi-37611	10	3	aims	aim	VERB
ajbspi-37611	10	4	to	to	PART
ajbspi-37611	10	5	provide	provide	VERB
ajbspi-37611	10	6	a	a	DET
ajbspi-37611	10	7	comprehensive	comprehensive	ADJ
ajbspi-37611	10	8	exploration	exploration	NOUN
ajbspi-37611	10	9	of	of	ADP
ajbspi-37611	10	10	the	the	DET
ajbspi-37611	10	11	advancements	advancement	NOUN
ajbspi-37611	10	12	in	in	ADP
ajbspi-37611	10	13	treating	treat	VERB
ajbspi-37611	10	14	advanced	advanced	ADJ
ajbspi-37611	10	15	ovarian	ovarian	ADJ
ajbspi-37611	10	16	cancer	cancer	NOUN
ajbspi-37611	10	17	by	by	ADP
ajbspi-37611	10	18	focusing	focus	VERB
ajbspi-37611	10	19	on	on	ADP
ajbspi-37611	10	20	the	the	DET
ajbspi-37611	10	21	pd-1	pd-1	NOUN
ajbspi-37611	10	22	/	/	SYM
ajbspi-37611	10	23	pd	pd	ADJ
ajbspi-37611	10	24	-	-	PROPN
ajbspi-37611	10	25	l1	l1	PROPN
ajbspi-37611	10	26	pathway	pathway	NOUN
ajbspi-37611	10	27	.	.	PUNCT
ajbspi-37611	11	1	by	by	ADP
ajbspi-37611	11	2	delving	delve	VERB
ajbspi-37611	11	3	into	into	ADP
ajbspi-37611	11	4	the	the	DET
ajbspi-37611	11	5	underlying	underlie	VERB
ajbspi-37611	11	6	mechanisms	mechanism	NOUN
ajbspi-37611	11	7	of	of	ADP
ajbspi-37611	11	8	pd-1	pd-1	NOUN
ajbspi-37611	11	9	/	/	SYM
ajbspi-37611	11	10	pdl1	pdl1	NOUN
ajbspi-37611	11	11	interactions	interaction	NOUN
ajbspi-37611	11	12	,	,	PUNCT
ajbspi-37611	11	13	analyzing	analyze	VERB
ajbspi-37611	11	14	recent	recent	ADJ
ajbspi-37611	11	15	clinical	clinical	ADJ
ajbspi-37611	11	16	trials	trial	NOUN
ajbspi-37611	11	17	,	,	PUNCT
ajbspi-37611	11	18	and	and	CCONJ
ajbspi-37611	11	19	evaluating	evaluate	VERB
ajbspi-37611	11	20	the	the	DET
ajbspi-37611	11	21	potential	potential	ADJ
ajbspi-37611	11	22	implications	implication	NOUN
ajbspi-37611	11	23	of	of	ADP
ajbspi-37611	11	24	these	these	DET
ajbspi-37611	11	25	therapies	therapy	NOUN
ajbspi-37611	11	26	,	,	PUNCT
ajbspi-37611	11	27	we	we	PRON
ajbspi-37611	11	28	aim	aim	VERB
ajbspi-37611	11	29	to	to	PART
ajbspi-37611	11	30	elucidate	elucidate	VERB
ajbspi-37611	11	31	the	the	DET
ajbspi-37611	11	32	evolving	evolve	VERB
ajbspi-37611	11	33	role	role	NOUN
ajbspi-37611	11	34	of	of	ADP
ajbspi-37611	11	35	immune	immune	ADJ
ajbspi-37611	11	36	checkpoint	checkpoint	NOUN
ajbspi-37611	11	37	inhibitors	inhibitor	NOUN
ajbspi-37611	11	38	in	in	ADP
ajbspi-37611	11	39	revolutionizing	revolutionize	VERB
ajbspi-37611	11	40	the	the	DET
ajbspi-37611	11	41	treatment	treatment	NOUN
ajbspi-37611	11	42	of	of	ADP
ajbspi-37611	11	43	advanced	advanced	ADJ
ajbspi-37611	11	44	ovarian	ovarian	ADJ
ajbspi-37611	11	45	cancer	cancer	NOUN
ajbspi-37611	11	46	.	.	PUNCT
ajbspi-37611	12	1	method	method	PROPN
ajbspi-37611	12	2	literature	literature	PROPN
ajbspi-37611	12	3	review	review	PROPN
ajbspi-37611	12	4	:	:	PUNCT
ajbspi-37611	12	5	conduct	conduct	VERB
ajbspi-37611	12	6	an	an	DET
ajbspi-37611	12	7	extensive	extensive	ADJ
ajbspi-37611	12	8	review	review	NOUN
ajbspi-37611	12	9	of	of	ADP
ajbspi-37611	12	10	the	the	DET
ajbspi-37611	12	11	literature	literature	NOUN
ajbspi-37611	12	12	to	to	PART
ajbspi-37611	12	13	gather	gather	VERB
ajbspi-37611	12	14	relevant	relevant	ADJ
ajbspi-37611	12	15	information	information	NOUN
ajbspi-37611	12	16	on	on	ADP
ajbspi-37611	12	17	the	the	DET
ajbspi-37611	12	18	pd-1	pd-1	NOUN
ajbspi-37611	12	19	/	/	SYM
ajbspi-37611	12	20	pd	pd	ADJ
ajbspi-37611	12	21	-	-	PROPN
ajbspi-37611	12	22	l1	l1	PROPN
ajbspi-37611	12	23	pathway	pathway	NOUN
ajbspi-37611	12	24	,	,	PUNCT
ajbspi-37611	12	25	immune	immune	ADJ
ajbspi-37611	12	26	checkpoint	checkpoint	NOUN
ajbspi-37611	12	27	inhibitors	inhibitor	NOUN
ajbspi-37611	12	28	,	,	PUNCT
ajbspi-37611	12	29	and	and	CCONJ
ajbspi-37611	12	30	their	their	PRON
ajbspi-37611	12	31	application	application	NOUN
ajbspi-37611	12	32	in	in	ADP
ajbspi-37611	12	33	advanced	advanced	ADJ
ajbspi-37611	12	34	ovarian	ovarian	ADJ
ajbspi-37611	12	35	cancer	cancer	NOUN
ajbspi-37611	12	36	therapy	therapy	NOUN
ajbspi-37611	12	37	.	.	PUNCT
ajbspi-37611	13	1	collect	collect	VERB
ajbspi-37611	13	2	data	datum	NOUN
ajbspi-37611	13	3	from	from	ADP
ajbspi-37611	13	4	clinical	clinical	ADJ
ajbspi-37611	13	5	trials	trial	NOUN
ajbspi-37611	13	6	,	,	PUNCT
ajbspi-37611	13	7	preclinical	preclinical	ADJ
ajbspi-37611	13	8	studies	study	NOUN
ajbspi-37611	13	9	,	,	PUNCT
ajbspi-37611	13	10	and	and	CCONJ
ajbspi-37611	13	11	reviews	review	NOUN
ajbspi-37611	13	12	to	to	PART
ajbspi-37611	13	13	provide	provide	VERB
ajbspi-37611	13	14	a	a	DET
ajbspi-37611	13	15	comprehensive	comprehensive	ADJ
ajbspi-37611	13	16	understanding	understanding	NOUN
ajbspi-37611	13	17	of	of	ADP
ajbspi-37611	13	18	the	the	DET
ajbspi-37611	13	19	topic	topic	NOUN
ajbspi-37611	13	20	.	.	PUNCT
ajbspi-37611	14	1	mechanistic	mechanistic	ADJ
ajbspi-37611	14	2	basis	basis	NOUN
ajbspi-37611	14	3	of	of	ADP
ajbspi-37611	14	4	pd-1	pd-1	ADP
ajbspi-37611	14	5	/	/	SYM
ajbspi-37611	14	6	pd	pd	ADJ
ajbspi-37611	14	7	-	-	PUNCT
ajbspi-37611	14	8	l1	l1	PROPN
ajbspi-37611	14	9	interaction	interaction	NOUN
ajbspi-37611	14	10	:	:	PUNCT
ajbspi-37611	14	11	examine	examine	VERB
ajbspi-37611	14	12	the	the	DET
ajbspi-37611	14	13	molecular	molecular	ADJ
ajbspi-37611	14	14	mechanisms	mechanism	NOUN
ajbspi-37611	14	15	underlying	underlie	VERB
ajbspi-37611	14	16	the	the	DET
ajbspi-37611	14	17	pd1	pd1	NOUN
ajbspi-37611	14	18	/	/	SYM
ajbspi-37611	14	19	pd	pd	NOUN
ajbspi-37611	14	20	-	-	PROPN
ajbspi-37611	14	21	l1	l1	PROPN
ajbspi-37611	14	22	pathway	pathway	NOUN
ajbspi-37611	14	23	,	,	PUNCT
ajbspi-37611	14	24	including	include	VERB
ajbspi-37611	14	25	its	its	PRON
ajbspi-37611	14	26	role	role	NOUN
ajbspi-37611	14	27	in	in	ADP
ajbspi-37611	14	28	immune	immune	ADJ
ajbspi-37611	14	29	suppression	suppression	NOUN
ajbspi-37611	14	30	and	and	CCONJ
ajbspi-37611	14	31	tumor	tumor	NOUN
ajbspi-37611	14	32	evasion	evasion	NOUN
ajbspi-37611	14	33	.	.	PUNCT
ajbspi-37611	15	1	explore	explore	VERB
ajbspi-37611	15	2	how	how	SCONJ
ajbspi-37611	15	3	pd-1	pd-1	ADP
ajbspi-37611	15	4	/	/	SYM
ajbspi-37611	15	5	pd	pd	ADJ
ajbspi-37611	15	6	-	-	PUNCT
ajbspi-37611	15	7	l1	l1	PROPN
ajbspi-37611	15	8	interactions	interaction	NOUN
ajbspi-37611	15	9	contribute	contribute	VERB
ajbspi-37611	15	10	to	to	ADP
ajbspi-37611	15	11	the	the	DET
ajbspi-37611	15	12	immune	immune	ADJ
ajbspi-37611	15	13	escape	escape	NOUN
ajbspi-37611	15	14	mechanisms	mechanism	NOUN
ajbspi-37611	15	15	exploited	exploit	VERB
ajbspi-37611	15	16	by	by	ADP
ajbspi-37611	15	17	ovarian	ovarian	ADJ
ajbspi-37611	15	18	cancer	cancer	NOUN
ajbspi-37611	15	19	cells	cell	NOUN
ajbspi-37611	15	20	.	.	PUNCT
ajbspi-37611	16	1	clinical	clinical	ADJ
ajbspi-37611	16	2	trials	trial	NOUN
ajbspi-37611	16	3	analysis	analysis	NOUN
ajbspi-37611	16	4	:	:	PUNCT
ajbspi-37611	16	5	analyze	analyze	VERB
ajbspi-37611	16	6	recent	recent	ADJ
ajbspi-37611	16	7	and	and	CCONJ
ajbspi-37611	16	8	ongoing	ongoing	ADJ
ajbspi-37611	16	9	clinical	clinical	ADJ
ajbspi-37611	16	10	trials	trial	NOUN
ajbspi-37611	16	11	involving	involve	VERB
ajbspi-37611	16	12	immune	immune	ADJ
ajbspi-37611	16	13	checkpoint	checkpoint	NOUN
ajbspi-37611	16	14	inhibitors	inhibitor	NOUN
ajbspi-37611	16	15	targeting	target	VERB
ajbspi-37611	16	16	the	the	DET
ajbspi-37611	16	17	pd-1	pd-1	NOUN
ajbspi-37611	16	18	/	/	SYM
ajbspi-37611	16	19	pd	pd	ADJ
ajbspi-37611	16	20	-	-	PROPN
ajbspi-37611	16	21	l1	l1	PROPN
ajbspi-37611	16	22	pathway	pathway	NOUN
ajbspi-37611	16	23	in	in	ADP
ajbspi-37611	16	24	advanced	advanced	ADJ
ajbspi-37611	16	25	ovarian	ovarian	ADJ
ajbspi-37611	16	26	cancer	cancer	NOUN
ajbspi-37611	16	27	.	.	PUNCT
ajbspi-37611	17	1	evaluate	evaluate	VERB
ajbspi-37611	17	2	trial	trial	NOUN
ajbspi-37611	17	3	design	design	NOUN
ajbspi-37611	17	4	,	,	PUNCT
ajbspi-37611	17	5	patient	patient	ADJ
ajbspi-37611	17	6	characteristics	characteristic	NOUN
ajbspi-37611	17	7	,	,	PUNCT
ajbspi-37611	17	8	treatment	treatment	NOUN
ajbspi-37611	17	9	regimens	regimen	NOUN
ajbspi-37611	17	10	,	,	PUNCT
ajbspi-37611	17	11	response	response	NOUN
ajbspi-37611	17	12	rates	rate	NOUN
ajbspi-37611	17	13	,	,	PUNCT
ajbspi-37611	17	14	and	and	CCONJ
ajbspi-37611	17	15	overall	overall	ADJ
ajbspi-37611	17	16	survival	survival	NOUN
ajbspi-37611	17	17	outcomes	outcome	NOUN
ajbspi-37611	17	18	.	.	PUNCT
ajbspi-37611	18	1	clinical	clinical	ADJ
ajbspi-37611	18	2	significance	significance	NOUN
ajbspi-37611	18	3	and	and	CCONJ
ajbspi-37611	18	4	challenges	challenge	NOUN
ajbspi-37611	18	5	:	:	PUNCT
ajbspi-37611	18	6	discuss	discuss	VERB
ajbspi-37611	18	7	the	the	DET
ajbspi-37611	18	8	clinical	clinical	ADJ
ajbspi-37611	18	9	significance	significance	NOUN
ajbspi-37611	18	10	of	of	ADP
ajbspi-37611	18	11	immune	immune	ADJ
ajbspi-37611	18	12	checkpoint	checkpoint	NOUN
ajbspi-37611	18	13	inhibitors	inhibitor	NOUN
ajbspi-37611	18	14	in	in	ADP
ajbspi-37611	18	15	advanced	advanced	ADJ
ajbspi-37611	18	16	ovarian	ovarian	ADJ
ajbspi-37611	18	17	cancer	cancer	NOUN
ajbspi-37611	18	18	therapy	therapy	NOUN
ajbspi-37611	18	19	,	,	PUNCT
ajbspi-37611	18	20	considering	consider	VERB
ajbspi-37611	18	21	their	their	PRON
ajbspi-37611	18	22	potential	potential	NOUN
ajbspi-37611	18	23	to	to	PART
ajbspi-37611	18	24	enhance	enhance	VERB
ajbspi-37611	18	25	response	response	NOUN
ajbspi-37611	18	26	rates	rate	NOUN
ajbspi-37611	18	27	and	and	CCONJ
ajbspi-37611	18	28	prolong	prolong	ADJ
ajbspi-37611	18	29	survival	survival	NOUN
ajbspi-37611	18	30	.	.	PUNCT
ajbspi-37611	19	1	address	address	NOUN
ajbspi-37611	19	2	challenges	challenge	NOUN
ajbspi-37611	19	3	and	and	CCONJ
ajbspi-37611	19	4	limitations	limitation	NOUN
ajbspi-37611	19	5	associated	associate	VERB
ajbspi-37611	19	6	with	with	ADP
ajbspi-37611	19	7	the	the	DET
ajbspi-37611	19	8	use	use	NOUN
ajbspi-37611	19	9	of	of	ADP
ajbspi-37611	19	10	pd-1	pd-1	NOUN
ajbspi-37611	19	11	/	/	SYM
ajbspi-37611	19	12	pd	pd	ADJ
ajbspi-37611	19	13	-	-	PUNCT
ajbspi-37611	19	14	l1	l1	PROPN
ajbspi-37611	19	15	inhibitors	inhibitor	NOUN
ajbspi-37611	19	16	,	,	PUNCT
ajbspi-37611	19	17	such	such	ADJ
ajbspi-37611	19	18	as	as	ADP
ajbspi-37611	19	19	resistance	resistance	NOUN
ajbspi-37611	19	20	mechanisms	mechanism	NOUN
ajbspi-37611	19	21	and	and	CCONJ
ajbspi-37611	19	22	adverse	adverse	ADJ
ajbspi-37611	19	23	effects	effect	NOUN
ajbspi-37611	19	24	.	.	PUNCT
ajbspi-37611	20	1	future	future	ADJ
ajbspi-37611	20	2	directions	direction	NOUN
ajbspi-37611	20	3	:	:	PUNCT
ajbspi-37611	20	4	explore	explore	VERB
ajbspi-37611	20	5	future	future	ADJ
ajbspi-37611	20	6	prospects	prospect	NOUN
ajbspi-37611	20	7	,	,	PUNCT
ajbspi-37611	20	8	including	include	VERB
ajbspi-37611	20	9	potential	potential	ADJ
ajbspi-37611	20	10	combination	combination	NOUN
ajbspi-37611	20	11	therapies	therapy	NOUN
ajbspi-37611	20	12	,	,	PUNCT
ajbspi-37611	20	13	predictive	predictive	ADJ
ajbspi-37611	20	14	biomarkers	biomarker	NOUN
ajbspi-37611	20	15	,	,	PUNCT
ajbspi-37611	20	16	and	and	CCONJ
ajbspi-37611	20	17	personalized	personalized	ADJ
ajbspi-37611	20	18	treatment	treatment	NOUN
ajbspi-37611	20	19	strategies	strategy	NOUN
ajbspi-37611	20	20	that	that	PRON
ajbspi-37611	20	21	optimize	optimize	VERB
ajbspi-37611	20	22	the	the	DET
ajbspi-37611	20	23	therapeutic	therapeutic	ADJ
ajbspi-37611	20	24	impact	impact	NOUN
ajbspi-37611	20	25	of	of	ADP
ajbspi-37611	20	26	pd-1	pd-1	ADP
ajbspi-37611	20	27	/	/	SYM
ajbspi-37611	20	28	pd	pd	ADJ
ajbspi-37611	20	29	-	-	PUNCT
ajbspi-37611	20	30	l1	l1	PROPN
ajbspi-37611	20	31	inhibitors	inhibitor	NOUN
ajbspi-37611	20	32	in	in	ADP
ajbspi-37611	20	33	advanced	advanced	ADJ
ajbspi-37611	20	34	ovarian	ovarian	ADJ
ajbspi-37611	20	35	cancer	cancer	NOUN
ajbspi-37611	20	36	.	.	PUNCT
ajbspi-37611	21	1	https://doi.org/10.37547/ajbspi/volume03issue03-01	https://doi.org/10.37547/ajbspi/volume03issue03-01	PROPN
ajbspi-37611	21	2	https://scholar.google.co.in/scholar?q=	https://scholar.google.co.in/scholar?q=	VERB
ajbspi-37611	21	3	https://www.mendeley.com/search/?page=1&query=	https://www.mendeley.com/search/?page=1&query=	ADJ
ajbspi-37611	21	4	volume	volume	NOUN
ajbspi-37611	21	5	03	03	NUM
ajbspi-37611	21	6	issue	issue	NOUN
ajbspi-37611	21	7	10	10	NUM
ajbspi-37611	21	8	-	-	SYM
ajbspi-37611	21	9	2023	2023	NUM
ajbspi-37611	21	10	3	3	NUM
ajbspi-37611	21	11	american	american	PROPN
ajbspi-37611	21	12	journal	journal	PROPN
ajbspi-37611	21	13	of	of	ADP
ajbspi-37611	21	14	biomedical	biomedical	PROPN
ajbspi-37611	21	15	science	science	PROPN
ajbspi-37611	21	16	&	&	CCONJ
ajbspi-37611	21	17	pharmaceutical	pharmaceutical	PROPN
ajbspi-37611	21	18	innovation	innovation	NOUN
ajbspi-37611	21	19	(	(	PUNCT
ajbspi-37611	21	20	issn	issn	PROPN
ajbspi-37611	21	21	–	–	PUNCT
ajbspi-37611	21	22	2771	2771	NUM
ajbspi-37611	21	23	-	-	SYM
ajbspi-37611	21	24	2753	2753	NUM
ajbspi-37611	21	25	)	)	PUNCT
ajbspi-37611	21	26	volume	volume	NOUN
ajbspi-37611	21	27	03	03	NUM
ajbspi-37611	21	28	issue	issue	NOUN
ajbspi-37611	21	29	10	10	NUM
ajbspi-37611	21	30	pages	page	NOUN
ajbspi-37611	21	31	:	:	PUNCT
ajbspi-37611	21	32	1	1	NUM
ajbspi-37611	21	33	-	-	SYM
ajbspi-37611	21	34	5	5	NUM
ajbspi-37611	21	35	sjif	sjif	NOUN
ajbspi-37611	21	36	impact	impact	NOUN
ajbspi-37611	21	37	factor	factor	NOUN
ajbspi-37611	21	38	(	(	PUNCT
ajbspi-37611	21	39	2021	2021	NUM
ajbspi-37611	21	40	:	:	PUNCT
ajbspi-37611	21	41	5	5	NUM
ajbspi-37611	21	42	.	.	NOUN
ajbspi-37611	21	43	705	705	NUM
ajbspi-37611	21	44	)	)	PUNCT
ajbspi-37611	21	45	(	(	PUNCT
ajbspi-37611	21	46	2022	2022	NUM
ajbspi-37611	21	47	:	:	PUNCT
ajbspi-37611	21	48	5	5	NUM
ajbspi-37611	21	49	.	.	NOUN
ajbspi-37611	21	50	705	705	NUM
ajbspi-37611	21	51	)	)	PUNCT
ajbspi-37611	21	52	(	(	PUNCT
ajbspi-37611	21	53	2023	2023	NUM
ajbspi-37611	21	54	:	:	PUNCT
ajbspi-37611	21	55	6.534	6.534	NUM
ajbspi-37611	21	56	)	)	PUNCT
ajbspi-37611	21	57	oclc	oclc	PROPN
ajbspi-37611	21	58	–	–	PUNCT
ajbspi-37611	21	59	1121105677	1121105677	NUM
ajbspi-37611	21	60	publisher	publisher	NOUN
ajbspi-37611	21	61	:	:	PUNCT
ajbspi-37611	21	62	oscar	oscar	NOUN
ajbspi-37611	21	63	publishing	publishing	NOUN
ajbspi-37611	21	64	services	service	NOUN
ajbspi-37611	21	65	servi	servi	PROPN
ajbspi-37611	21	66	data	datum	NOUN
ajbspi-37611	21	67	synthesis	synthesis	NOUN
ajbspi-37611	21	68	and	and	CCONJ
ajbspi-37611	21	69	discussion	discussion	NOUN
ajbspi-37611	21	70	:	:	PUNCT
ajbspi-37611	21	71	synthesize	synthesize	VERB
ajbspi-37611	21	72	the	the	DET
ajbspi-37611	21	73	gathered	gather	VERB
ajbspi-37611	21	74	information	information	NOUN
ajbspi-37611	21	75	and	and	CCONJ
ajbspi-37611	21	76	present	present	VERB
ajbspi-37611	21	77	a	a	DET
ajbspi-37611	21	78	comprehensive	comprehensive	ADJ
ajbspi-37611	21	79	overview	overview	NOUN
ajbspi-37611	21	80	of	of	ADP
ajbspi-37611	21	81	the	the	DET
ajbspi-37611	21	82	role	role	NOUN
ajbspi-37611	21	83	of	of	ADP
ajbspi-37611	21	84	pd-1	pd-1	ADP
ajbspi-37611	21	85	/	/	SYM
ajbspi-37611	21	86	pd	pd	ADJ
ajbspi-37611	21	87	-	-	PUNCT
ajbspi-37611	21	88	l1	l1	PROPN
ajbspi-37611	21	89	inhibitors	inhibitor	NOUN
ajbspi-37611	21	90	in	in	ADP
ajbspi-37611	21	91	revolutionizing	revolutionize	VERB
ajbspi-37611	21	92	advanced	advanced	ADJ
ajbspi-37611	21	93	ovarian	ovarian	ADJ
ajbspi-37611	21	94	cancer	cancer	NOUN
ajbspi-37611	21	95	therapy	therapy	NOUN
ajbspi-37611	21	96	.	.	PUNCT
ajbspi-37611	22	1	engage	engage	VERB
ajbspi-37611	22	2	in	in	ADP
ajbspi-37611	22	3	a	a	DET
ajbspi-37611	22	4	critical	critical	ADJ
ajbspi-37611	22	5	discussion	discussion	NOUN
ajbspi-37611	22	6	of	of	ADP
ajbspi-37611	22	7	the	the	DET
ajbspi-37611	22	8	potential	potential	ADJ
ajbspi-37611	22	9	benefits	benefit	NOUN
ajbspi-37611	22	10	,	,	PUNCT
ajbspi-37611	22	11	challenges	challenge	NOUN
ajbspi-37611	22	12	,	,	PUNCT
ajbspi-37611	22	13	and	and	CCONJ
ajbspi-37611	22	14	implications	implication	NOUN
ajbspi-37611	22	15	of	of	ADP
ajbspi-37611	22	16	these	these	DET
ajbspi-37611	22	17	therapies	therapy	NOUN
ajbspi-37611	22	18	in	in	ADP
ajbspi-37611	22	19	clinical	clinical	ADJ
ajbspi-37611	22	20	practice	practice	NOUN
ajbspi-37611	22	21	.	.	PUNCT
ajbspi-37611	23	1	by	by	ADP
ajbspi-37611	23	2	meticulously	meticulously	ADV
ajbspi-37611	23	3	following	follow	VERB
ajbspi-37611	23	4	these	these	DET
ajbspi-37611	23	5	methodological	methodological	ADJ
ajbspi-37611	23	6	steps	step	NOUN
ajbspi-37611	23	7	,	,	PUNCT
ajbspi-37611	23	8	this	this	DET
ajbspi-37611	23	9	review	review	NOUN
ajbspi-37611	23	10	aims	aim	VERB
ajbspi-37611	23	11	to	to	PART
ajbspi-37611	23	12	provide	provide	VERB
ajbspi-37611	23	13	a	a	DET
ajbspi-37611	23	14	comprehensive	comprehensive	ADJ
ajbspi-37611	23	15	overview	overview	NOUN
ajbspi-37611	23	16	of	of	ADP
ajbspi-37611	23	17	the	the	DET
ajbspi-37611	23	18	transformative	transformative	ADJ
ajbspi-37611	23	19	potential	potential	NOUN
ajbspi-37611	23	20	of	of	ADP
ajbspi-37611	23	21	immune	immune	ADJ
ajbspi-37611	23	22	checkpoint	checkpoint	NOUN
ajbspi-37611	23	23	inhibitors	inhibitor	NOUN
ajbspi-37611	23	24	targeting	target	VERB
ajbspi-37611	23	25	the	the	DET
ajbspi-37611	23	26	pd-1	pd-1	NOUN
ajbspi-37611	23	27	/	/	SYM
ajbspi-37611	23	28	pd	pd	ADJ
ajbspi-37611	23	29	-	-	PROPN
ajbspi-37611	23	30	l1	l1	PROPN
ajbspi-37611	23	31	pathway	pathway	NOUN
ajbspi-37611	23	32	in	in	ADP
ajbspi-37611	23	33	advanced	advanced	ADJ
ajbspi-37611	23	34	ovarian	ovarian	ADJ
ajbspi-37611	23	35	cancer	cancer	NOUN
ajbspi-37611	23	36	therapy	therapy	NOUN
ajbspi-37611	23	37	.	.	PUNCT
ajbspi-37611	24	1	the	the	DET
ajbspi-37611	24	2	synthesis	synthesis	NOUN
ajbspi-37611	24	3	of	of	ADP
ajbspi-37611	24	4	mechanistic	mechanistic	ADJ
ajbspi-37611	24	5	insights	insight	NOUN
ajbspi-37611	24	6	,	,	PUNCT
ajbspi-37611	24	7	clinical	clinical	ADJ
ajbspi-37611	24	8	trial	trial	NOUN
ajbspi-37611	24	9	data	datum	NOUN
ajbspi-37611	24	10	,	,	PUNCT
ajbspi-37611	24	11	and	and	CCONJ
ajbspi-37611	24	12	future	future	ADJ
ajbspi-37611	24	13	prospects	prospect	NOUN
ajbspi-37611	24	14	will	will	AUX
ajbspi-37611	24	15	contribute	contribute	VERB
ajbspi-37611	24	16	to	to	ADP
ajbspi-37611	24	17	our	our	PRON
ajbspi-37611	24	18	understanding	understanding	NOUN
ajbspi-37611	24	19	of	of	ADP
ajbspi-37611	24	20	the	the	DET
ajbspi-37611	24	21	evolving	evolve	VERB
ajbspi-37611	24	22	treatment	treatment	NOUN
ajbspi-37611	24	23	landscape	landscape	NOUN
ajbspi-37611	24	24	in	in	ADP
ajbspi-37611	24	25	ovarian	ovarian	ADJ
ajbspi-37611	24	26	cancer	cancer	NOUN
ajbspi-37611	24	27	and	and	CCONJ
ajbspi-37611	24	28	the	the	DET
ajbspi-37611	24	29	potential	potential	NOUN
ajbspi-37611	24	30	of	of	ADP
ajbspi-37611	24	31	immune	immune	ADJ
ajbspi-37611	24	32	checkpoint	checkpoint	NOUN
ajbspi-37611	24	33	inhibitors	inhibitor	NOUN
ajbspi-37611	24	34	to	to	PART
ajbspi-37611	24	35	reshape	reshape	VERB
ajbspi-37611	24	36	its	its	PRON
ajbspi-37611	24	37	trajectory	trajectory	NOUN
ajbspi-37611	24	38	.	.	PUNCT
ajbspi-37611	25	1	results	result	VERB
ajbspi-37611	25	2	the	the	DET
ajbspi-37611	25	3	comprehensive	comprehensive	ADJ
ajbspi-37611	25	4	review	review	NOUN
ajbspi-37611	25	5	on	on	ADP
ajbspi-37611	25	6	the	the	DET
ajbspi-37611	25	7	role	role	NOUN
ajbspi-37611	25	8	of	of	ADP
ajbspi-37611	25	9	the	the	DET
ajbspi-37611	25	10	pd-1	pd-1	ADJ
ajbspi-37611	25	11	/	/	SYM
ajbspi-37611	25	12	pdl1	pdl1	ADJ
ajbspi-37611	25	13	pathway	pathway	NOUN
ajbspi-37611	25	14	in	in	ADP
ajbspi-37611	25	15	revolutionizing	revolutionize	VERB
ajbspi-37611	25	16	advanced	advanced	ADJ
ajbspi-37611	25	17	ovarian	ovarian	ADJ
ajbspi-37611	25	18	cancer	cancer	NOUN
ajbspi-37611	25	19	therapy	therapy	NOUN
ajbspi-37611	25	20	unveiled	unveil	VERB
ajbspi-37611	25	21	significant	significant	ADJ
ajbspi-37611	25	22	insights	insight	NOUN
ajbspi-37611	25	23	.	.	PUNCT
ajbspi-37611	26	1	the	the	DET
ajbspi-37611	26	2	mechanistic	mechanistic	ADJ
ajbspi-37611	26	3	exploration	exploration	NOUN
ajbspi-37611	26	4	highlighted	highlight	VERB
ajbspi-37611	26	5	the	the	DET
ajbspi-37611	26	6	immunoregulatory	immunoregulatory	ADJ
ajbspi-37611	26	7	significance	significance	NOUN
ajbspi-37611	26	8	of	of	ADP
ajbspi-37611	26	9	pd-1	pd-1	ADP
ajbspi-37611	26	10	/	/	SYM
ajbspi-37611	26	11	pd	pd	ADJ
ajbspi-37611	26	12	-	-	PUNCT
ajbspi-37611	26	13	l1	l1	PROPN
ajbspi-37611	26	14	interactions	interaction	NOUN
ajbspi-37611	26	15	,	,	PUNCT
ajbspi-37611	26	16	particularly	particularly	ADV
ajbspi-37611	26	17	in	in	ADP
ajbspi-37611	26	18	promoting	promote	VERB
ajbspi-37611	26	19	immune	immune	ADJ
ajbspi-37611	26	20	evasion	evasion	NOUN
ajbspi-37611	26	21	within	within	ADP
ajbspi-37611	26	22	the	the	DET
ajbspi-37611	26	23	tumor	tumor	NOUN
ajbspi-37611	26	24	microenvironment	microenvironment	NOUN
ajbspi-37611	26	25	.	.	PUNCT
ajbspi-37611	27	1	the	the	DET
ajbspi-37611	27	2	analysis	analysis	NOUN
ajbspi-37611	27	3	of	of	ADP
ajbspi-37611	27	4	recent	recent	ADJ
ajbspi-37611	27	5	clinical	clinical	ADJ
ajbspi-37611	27	6	trials	trial	NOUN
ajbspi-37611	27	7	indicated	indicate	VERB
ajbspi-37611	27	8	promising	promise	VERB
ajbspi-37611	27	9	outcomes	outcome	NOUN
ajbspi-37611	27	10	for	for	ADP
ajbspi-37611	27	11	immune	immune	ADJ
ajbspi-37611	27	12	checkpoint	checkpoint	NOUN
ajbspi-37611	27	13	inhibitors	inhibitor	NOUN
ajbspi-37611	27	14	targeting	target	VERB
ajbspi-37611	27	15	pd-1	pd-1	ADP
ajbspi-37611	27	16	/	/	SYM
ajbspi-37611	27	17	pd	pd	NOUN
ajbspi-37611	27	18	-	-	PROPN
ajbspi-37611	27	19	l1	l1	PROPN
ajbspi-37611	27	20	in	in	ADP
ajbspi-37611	27	21	advanced	advanced	ADJ
ajbspi-37611	27	22	ovarian	ovarian	ADJ
ajbspi-37611	27	23	cancer	cancer	NOUN
ajbspi-37611	27	24	,	,	PUNCT
ajbspi-37611	27	25	including	include	VERB
ajbspi-37611	27	26	notable	notable	ADJ
ajbspi-37611	27	27	response	response	NOUN
ajbspi-37611	27	28	rates	rate	NOUN
ajbspi-37611	27	29	and	and	CCONJ
ajbspi-37611	27	30	prolonged	prolonged	ADJ
ajbspi-37611	27	31	survival	survival	NOUN
ajbspi-37611	27	32	in	in	ADP
ajbspi-37611	27	33	some	some	DET
ajbspi-37611	27	34	cases	case	NOUN
ajbspi-37611	27	35	.	.	PUNCT
ajbspi-37611	28	1	discussion	discussion	NOUN
ajbspi-37611	28	2	the	the	DET
ajbspi-37611	28	3	discussion	discussion	NOUN
ajbspi-37611	28	4	delved	delve	VERB
ajbspi-37611	28	5	into	into	ADP
ajbspi-37611	28	6	the	the	DET
ajbspi-37611	28	7	clinical	clinical	ADJ
ajbspi-37611	28	8	significance	significance	NOUN
ajbspi-37611	28	9	of	of	ADP
ajbspi-37611	28	10	pd-1	pd-1	ADP
ajbspi-37611	28	11	/	/	SYM
ajbspi-37611	28	12	pd	pd	ADJ
ajbspi-37611	28	13	-	-	PUNCT
ajbspi-37611	28	14	l1	l1	PROPN
ajbspi-37611	28	15	inhibitors	inhibitor	NOUN
ajbspi-37611	28	16	in	in	ADP
ajbspi-37611	28	17	advanced	advanced	ADJ
ajbspi-37611	28	18	ovarian	ovarian	ADJ
ajbspi-37611	28	19	cancer	cancer	NOUN
ajbspi-37611	28	20	therapy	therapy	NOUN
ajbspi-37611	28	21	.	.	PUNCT
ajbspi-37611	29	1	the	the	DET
ajbspi-37611	29	2	success	success	NOUN
ajbspi-37611	29	3	observed	observe	VERB
ajbspi-37611	29	4	in	in	ADP
ajbspi-37611	29	5	other	other	ADJ
ajbspi-37611	29	6	malignancies	malignancy	NOUN
ajbspi-37611	29	7	with	with	ADP
ajbspi-37611	29	8	immune	immune	ADJ
ajbspi-37611	29	9	checkpoint	checkpoint	NOUN
ajbspi-37611	29	10	inhibitors	inhibitor	NOUN
ajbspi-37611	29	11	has	have	AUX
ajbspi-37611	29	12	sparked	spark	VERB
ajbspi-37611	29	13	enthusiasm	enthusiasm	NOUN
ajbspi-37611	29	14	for	for	ADP
ajbspi-37611	29	15	their	their	PRON
ajbspi-37611	29	16	potential	potential	NOUN
ajbspi-37611	29	17	in	in	ADP
ajbspi-37611	29	18	a	a	DET
ajbspi-37611	29	19	disease	disease	NOUN
ajbspi-37611	29	20	characterized	characterize	VERB
ajbspi-37611	29	21	by	by	ADP
ajbspi-37611	29	22	limited	limited	ADJ
ajbspi-37611	29	23	treatment	treatment	NOUN
ajbspi-37611	29	24	options	option	NOUN
ajbspi-37611	29	25	.	.	PUNCT
ajbspi-37611	30	1	the	the	DET
ajbspi-37611	30	2	concept	concept	NOUN
ajbspi-37611	30	3	of	of	ADP
ajbspi-37611	30	4	unleashing	unleash	VERB
ajbspi-37611	30	5	the	the	DET
ajbspi-37611	30	6	immune	immune	ADJ
ajbspi-37611	30	7	system	system	NOUN
ajbspi-37611	30	8	against	against	ADP
ajbspi-37611	30	9	ovarian	ovarian	ADJ
ajbspi-37611	30	10	cancer	cancer	NOUN
ajbspi-37611	30	11	,	,	PUNCT
ajbspi-37611	30	12	which	which	PRON
ajbspi-37611	30	13	has	have	AUX
ajbspi-37611	30	14	historically	historically	ADV
ajbspi-37611	30	15	been	be	AUX
ajbspi-37611	30	16	challenging	challenge	VERB
ajbspi-37611	30	17	to	to	PART
ajbspi-37611	30	18	target	target	VERB
ajbspi-37611	30	19	,	,	PUNCT
ajbspi-37611	30	20	holds	hold	VERB
ajbspi-37611	30	21	great	great	ADJ
ajbspi-37611	30	22	promise	promise	NOUN
ajbspi-37611	30	23	.	.	PUNCT
ajbspi-37611	31	1	however	however	ADV
ajbspi-37611	31	2	,	,	PUNCT
ajbspi-37611	31	3	challenges	challenge	NOUN
ajbspi-37611	31	4	such	such	ADJ
ajbspi-37611	31	5	as	as	ADP
ajbspi-37611	31	6	resistance	resistance	NOUN
ajbspi-37611	31	7	mechanisms	mechanism	NOUN
ajbspi-37611	31	8	,	,	PUNCT
ajbspi-37611	31	9	patient	patient	ADJ
ajbspi-37611	31	10	selection	selection	NOUN
ajbspi-37611	31	11	,	,	PUNCT
ajbspi-37611	31	12	and	and	CCONJ
ajbspi-37611	31	13	immune	immune	NOUN
ajbspi-37611	31	14	-	-	PUNCT
ajbspi-37611	31	15	related	relate	VERB
ajbspi-37611	31	16	adverse	adverse	ADJ
ajbspi-37611	31	17	events	event	NOUN
ajbspi-37611	31	18	were	be	AUX
ajbspi-37611	31	19	also	also	ADV
ajbspi-37611	31	20	acknowledged	acknowledge	VERB
ajbspi-37611	31	21	,	,	PUNCT
ajbspi-37611	31	22	underscoring	underscore	VERB
ajbspi-37611	31	23	the	the	DET
ajbspi-37611	31	24	importance	importance	NOUN
ajbspi-37611	31	25	of	of	ADP
ajbspi-37611	31	26	optimizing	optimize	VERB
ajbspi-37611	31	27	treatment	treatment	NOUN
ajbspi-37611	31	28	strategies	strategy	NOUN
ajbspi-37611	31	29	.	.	PUNCT
ajbspi-37611	32	1	the	the	DET
ajbspi-37611	32	2	review	review	NOUN
ajbspi-37611	32	3	also	also	ADV
ajbspi-37611	32	4	contemplated	contemplate	VERB
ajbspi-37611	32	5	the	the	DET
ajbspi-37611	32	6	potential	potential	NOUN
ajbspi-37611	32	7	of	of	ADP
ajbspi-37611	32	8	combining	combine	VERB
ajbspi-37611	32	9	immune	immune	ADJ
ajbspi-37611	32	10	checkpoint	checkpoint	NOUN
ajbspi-37611	32	11	inhibitors	inhibitor	NOUN
ajbspi-37611	32	12	with	with	ADP
ajbspi-37611	32	13	other	other	ADJ
ajbspi-37611	32	14	therapeutic	therapeutic	ADJ
ajbspi-37611	32	15	modalities	modality	NOUN
ajbspi-37611	32	16	,	,	PUNCT
ajbspi-37611	32	17	including	include	VERB
ajbspi-37611	32	18	chemotherapy	chemotherapy	NOUN
ajbspi-37611	32	19	and	and	CCONJ
ajbspi-37611	32	20	targeted	target	VERB
ajbspi-37611	32	21	agents	agent	NOUN
ajbspi-37611	32	22	.	.	PUNCT
ajbspi-37611	33	1	the	the	DET
ajbspi-37611	33	2	discussion	discussion	NOUN
ajbspi-37611	33	3	emphasized	emphasize	VERB
ajbspi-37611	33	4	the	the	DET
ajbspi-37611	33	5	significance	significance	NOUN
ajbspi-37611	33	6	of	of	ADP
ajbspi-37611	33	7	identifying	identify	VERB
ajbspi-37611	33	8	predictive	predictive	ADJ
ajbspi-37611	33	9	biomarkers	biomarker	NOUN
ajbspi-37611	33	10	to	to	PART
ajbspi-37611	33	11	guide	guide	VERB
ajbspi-37611	33	12	patient	patient	ADJ
ajbspi-37611	33	13	selection	selection	NOUN
ajbspi-37611	33	14	and	and	CCONJ
ajbspi-37611	33	15	maximize	maximize	VERB
ajbspi-37611	33	16	the	the	DET
ajbspi-37611	33	17	clinical	clinical	ADJ
ajbspi-37611	33	18	benefit	benefit	NOUN
ajbspi-37611	33	19	of	of	ADP
ajbspi-37611	33	20	these	these	DET
ajbspi-37611	33	21	therapies	therapy	NOUN
ajbspi-37611	33	22	.	.	PUNCT
ajbspi-37611	34	1	conclusion	conclusion	NOUN
ajbspi-37611	34	2	in	in	ADP
ajbspi-37611	34	3	conclusion	conclusion	NOUN
ajbspi-37611	34	4	,	,	PUNCT
ajbspi-37611	34	5	this	this	DET
ajbspi-37611	34	6	review	review	NOUN
ajbspi-37611	34	7	showcased	showcase	VERB
ajbspi-37611	34	8	the	the	DET
ajbspi-37611	34	9	transformative	transformative	ADJ
ajbspi-37611	34	10	potential	potential	NOUN
ajbspi-37611	34	11	of	of	ADP
ajbspi-37611	34	12	immune	immune	ADJ
ajbspi-37611	34	13	checkpoint	checkpoint	NOUN
ajbspi-37611	34	14	inhibitors	inhibitor	NOUN
ajbspi-37611	34	15	targeting	target	VERB
ajbspi-37611	34	16	the	the	DET
ajbspi-37611	34	17	pd-1	pd-1	NOUN
ajbspi-37611	34	18	/	/	SYM
ajbspi-37611	34	19	pd	pd	ADJ
ajbspi-37611	34	20	-	-	PROPN
ajbspi-37611	34	21	l1	l1	PROPN
ajbspi-37611	34	22	pathway	pathway	NOUN
ajbspi-37611	34	23	in	in	ADP
ajbspi-37611	34	24	https://doi.org/10.37547/ajbspi/volume03issue03-01	https://doi.org/10.37547/ajbspi/volume03issue03-01	PROPN
ajbspi-37611	34	25	https://scholar.google.co.in/scholar?q=	https://scholar.google.co.in/scholar?q=	NOUN
ajbspi-37611	34	26	https://www.mendeley.com/search/?page=1&query=	https://www.mendeley.com/search/?page=1&query=	ADJ
ajbspi-37611	34	27	volume	volume	NOUN
ajbspi-37611	34	28	03	03	NUM
ajbspi-37611	34	29	issue	issue	NOUN
ajbspi-37611	34	30	10	10	NUM
ajbspi-37611	34	31	-	-	SYM
ajbspi-37611	34	32	2023	2023	NUM
ajbspi-37611	34	33	4	4	NUM
ajbspi-37611	34	34	american	american	ADJ
ajbspi-37611	34	35	journal	journal	NOUN
ajbspi-37611	34	36	of	of	ADP
ajbspi-37611	34	37	biomedical	biomedical	PROPN
ajbspi-37611	34	38	science	science	PROPN
ajbspi-37611	34	39	&	&	CCONJ
ajbspi-37611	34	40	pharmaceutical	pharmaceutical	PROPN
ajbspi-37611	34	41	innovation	innovation	NOUN
ajbspi-37611	34	42	(	(	PUNCT
ajbspi-37611	34	43	issn	issn	PROPN
ajbspi-37611	34	44	–	–	PUNCT
ajbspi-37611	34	45	2771	2771	NUM
ajbspi-37611	34	46	-	-	SYM
ajbspi-37611	34	47	2753	2753	NUM
ajbspi-37611	34	48	)	)	PUNCT
ajbspi-37611	34	49	volume	volume	NOUN
ajbspi-37611	34	50	03	03	NUM
ajbspi-37611	34	51	issue	issue	NOUN
ajbspi-37611	34	52	10	10	NUM
ajbspi-37611	34	53	pages	page	NOUN
ajbspi-37611	34	54	:	:	PUNCT
ajbspi-37611	34	55	1	1	NUM
ajbspi-37611	34	56	-	-	SYM
ajbspi-37611	34	57	5	5	NUM
ajbspi-37611	34	58	sjif	sjif	NOUN
ajbspi-37611	34	59	impact	impact	NOUN
ajbspi-37611	34	60	factor	factor	NOUN
ajbspi-37611	34	61	(	(	PUNCT
ajbspi-37611	34	62	2021	2021	NUM
ajbspi-37611	34	63	:	:	PUNCT
ajbspi-37611	34	64	5	5	NUM
ajbspi-37611	34	65	.	.	NOUN
ajbspi-37611	34	66	705	705	NUM
ajbspi-37611	34	67	)	)	PUNCT
ajbspi-37611	34	68	(	(	PUNCT
ajbspi-37611	34	69	2022	2022	NUM
ajbspi-37611	34	70	:	:	PUNCT
ajbspi-37611	34	71	5	5	NUM
ajbspi-37611	34	72	.	.	NOUN
ajbspi-37611	34	73	705	705	NUM
ajbspi-37611	34	74	)	)	PUNCT
ajbspi-37611	34	75	(	(	PUNCT
ajbspi-37611	34	76	2023	2023	NUM
ajbspi-37611	34	77	:	:	PUNCT
ajbspi-37611	34	78	6.534	6.534	NUM
ajbspi-37611	34	79	)	)	PUNCT
ajbspi-37611	34	80	oclc	oclc	PROPN
ajbspi-37611	34	81	–	–	PUNCT
ajbspi-37611	34	82	1121105677	1121105677	NUM
ajbspi-37611	34	83	publisher	publisher	NOUN
ajbspi-37611	34	84	:	:	PUNCT
ajbspi-37611	34	85	oscar	oscar	NOUN
ajbspi-37611	34	86	publishing	publishing	NOUN
ajbspi-37611	34	87	services	service	NOUN
ajbspi-37611	34	88	servi	servi	ADJ
ajbspi-37611	34	89	advancing	advance	VERB
ajbspi-37611	34	90	ovarian	ovarian	ADJ
ajbspi-37611	34	91	cancer	cancer	NOUN
ajbspi-37611	34	92	therapy	therapy	NOUN
ajbspi-37611	34	93	.	.	PUNCT
ajbspi-37611	35	1	the	the	DET
ajbspi-37611	35	2	synthesis	synthesis	NOUN
ajbspi-37611	35	3	of	of	ADP
ajbspi-37611	35	4	mechanistic	mechanistic	ADJ
ajbspi-37611	35	5	insights	insight	NOUN
ajbspi-37611	35	6	,	,	PUNCT
ajbspi-37611	35	7	clinical	clinical	ADJ
ajbspi-37611	35	8	trial	trial	NOUN
ajbspi-37611	35	9	data	datum	NOUN
ajbspi-37611	35	10	,	,	PUNCT
ajbspi-37611	35	11	and	and	CCONJ
ajbspi-37611	35	12	future	future	ADJ
ajbspi-37611	35	13	prospects	prospect	NOUN
ajbspi-37611	35	14	underlines	underline	VERB
ajbspi-37611	35	15	the	the	DET
ajbspi-37611	35	16	promise	promise	NOUN
ajbspi-37611	35	17	of	of	ADP
ajbspi-37611	35	18	this	this	DET
ajbspi-37611	35	19	approach	approach	NOUN
ajbspi-37611	35	20	to	to	PART
ajbspi-37611	35	21	reshape	reshape	VERB
ajbspi-37611	35	22	the	the	DET
ajbspi-37611	35	23	therapeutic	therapeutic	ADJ
ajbspi-37611	35	24	landscape	landscape	NOUN
ajbspi-37611	35	25	for	for	ADP
ajbspi-37611	35	26	advanced	advanced	ADJ
ajbspi-37611	35	27	ovarian	ovarian	ADJ
ajbspi-37611	35	28	cancer	cancer	NOUN
ajbspi-37611	35	29	.	.	PUNCT
ajbspi-37611	36	1	while	while	SCONJ
ajbspi-37611	36	2	challenges	challenge	NOUN
ajbspi-37611	36	3	remain	remain	VERB
ajbspi-37611	36	4	,	,	PUNCT
ajbspi-37611	36	5	the	the	DET
ajbspi-37611	36	6	clinical	clinical	ADJ
ajbspi-37611	36	7	successes	success	NOUN
ajbspi-37611	36	8	observed	observe	VERB
ajbspi-37611	36	9	in	in	ADP
ajbspi-37611	36	10	other	other	ADJ
ajbspi-37611	36	11	malignancies	malignancy	NOUN
ajbspi-37611	36	12	ignite	ignite	VERB
ajbspi-37611	36	13	hope	hope	NOUN
ajbspi-37611	36	14	for	for	ADP
ajbspi-37611	36	15	a	a	DET
ajbspi-37611	36	16	similar	similar	ADJ
ajbspi-37611	36	17	paradigm	paradigm	NOUN
ajbspi-37611	36	18	shift	shift	NOUN
ajbspi-37611	36	19	in	in	ADP
ajbspi-37611	36	20	ovarian	ovarian	ADJ
ajbspi-37611	36	21	cancer	cancer	NOUN
ajbspi-37611	36	22	treatment	treatment	NOUN
ajbspi-37611	36	23	.	.	PUNCT
ajbspi-37611	37	1	by	by	ADP
ajbspi-37611	37	2	targeting	target	VERB
ajbspi-37611	37	3	immune	immune	ADJ
ajbspi-37611	37	4	checkpoints	checkpoint	NOUN
ajbspi-37611	37	5	,	,	PUNCT
ajbspi-37611	37	6	we	we	PRON
ajbspi-37611	37	7	embark	embark	VERB
ajbspi-37611	37	8	on	on	ADP
ajbspi-37611	37	9	a	a	DET
ajbspi-37611	37	10	new	new	ADJ
ajbspi-37611	37	11	era	era	NOUN
ajbspi-37611	37	12	of	of	ADP
ajbspi-37611	37	13	treatment	treatment	NOUN
ajbspi-37611	37	14	,	,	PUNCT
ajbspi-37611	37	15	aiming	aim	VERB
ajbspi-37611	37	16	to	to	ADP
ajbspi-37611	37	17	harness	harness	NOUN
ajbspi-37611	37	18	the	the	DET
ajbspi-37611	37	19	immune	immune	ADJ
ajbspi-37611	37	20	system	system	NOUN
ajbspi-37611	37	21	's	's	PART
ajbspi-37611	37	22	power	power	NOUN
ajbspi-37611	37	23	to	to	PART
ajbspi-37611	37	24	combat	combat	VERB
ajbspi-37611	37	25	this	this	DET
ajbspi-37611	37	26	complex	complex	ADJ
ajbspi-37611	37	27	and	and	CCONJ
ajbspi-37611	37	28	aggressive	aggressive	ADJ
ajbspi-37611	37	29	disease	disease	NOUN
ajbspi-37611	37	30	.	.	PUNCT
ajbspi-37611	38	1	as	as	SCONJ
ajbspi-37611	38	2	ongoing	ongoing	ADJ
ajbspi-37611	38	3	research	research	NOUN
ajbspi-37611	38	4	continues	continue	VERB
ajbspi-37611	38	5	to	to	PART
ajbspi-37611	38	6	refine	refine	VERB
ajbspi-37611	38	7	patient	patient	ADJ
ajbspi-37611	38	8	selection	selection	NOUN
ajbspi-37611	38	9	,	,	PUNCT
ajbspi-37611	38	10	therapeutic	therapeutic	ADJ
ajbspi-37611	38	11	combinations	combination	NOUN
ajbspi-37611	38	12	,	,	PUNCT
ajbspi-37611	38	13	and	and	CCONJ
ajbspi-37611	38	14	monitoring	monitoring	NOUN
ajbspi-37611	38	15	strategies	strategy	NOUN
ajbspi-37611	38	16	,	,	PUNCT
ajbspi-37611	38	17	immune	immune	ADJ
ajbspi-37611	38	18	checkpoint	checkpoint	NOUN
ajbspi-37611	38	19	inhibitors	inhibitor	NOUN
ajbspi-37611	38	20	have	have	VERB
ajbspi-37611	38	21	the	the	DET
ajbspi-37611	38	22	potential	potential	NOUN
ajbspi-37611	38	23	to	to	PART
ajbspi-37611	38	24	revolutionize	revolutionize	VERB
ajbspi-37611	38	25	the	the	DET
ajbspi-37611	38	26	trajectory	trajectory	NOUN
ajbspi-37611	38	27	of	of	ADP
ajbspi-37611	38	28	advanced	advanced	ADJ
ajbspi-37611	38	29	ovarian	ovarian	ADJ
ajbspi-37611	38	30	cancer	cancer	NOUN
ajbspi-37611	38	31	therapy	therapy	NOUN
ajbspi-37611	38	32	,	,	PUNCT
ajbspi-37611	38	33	ultimately	ultimately	ADV
ajbspi-37611	38	34	improving	improve	VERB
ajbspi-37611	38	35	patient	patient	ADJ
ajbspi-37611	38	36	outcomes	outcome	NOUN
ajbspi-37611	38	37	and	and	CCONJ
ajbspi-37611	38	38	extending	extend	VERB
ajbspi-37611	38	39	survival	survival	NOUN
ajbspi-37611	38	40	in	in	ADP
ajbspi-37611	38	41	a	a	DET
ajbspi-37611	38	42	historically	historically	ADV
ajbspi-37611	38	43	challenging	challenging	ADJ
ajbspi-37611	38	44	context	context	NOUN
ajbspi-37611	38	45	.	.	PUNCT
ajbspi-37611	39	1	references	reference	NOUN
ajbspi-37611	39	2	1	1	NUM
ajbspi-37611	39	3	.	.	PUNCT
ajbspi-37611	39	4	bulowski	bulowski	PROPN
ajbspi-37611	39	5	rm	rm	PROPN
ajbspi-37611	39	6	,	,	PUNCT
ajbspi-37611	39	7	ozole	ozole	PROPN
ajbspi-37611	39	8	rf	rf	NOUN
ajbspi-37611	39	9	,	,	PUNCT
ajbspi-37611	39	10	markman	markman	NOUN
ajbspi-37611	39	11	m	m	PROPN
ajbspi-37611	39	12	(	(	PUNCT
ajbspi-37611	39	13	2007	2007	NUM
ajbspi-37611	39	14	)	)	PUNCT
ajbspi-37611	39	15	the	the	DET
ajbspi-37611	39	16	management	management	NOUN
ajbspi-37611	39	17	of	of	ADP
ajbspi-37611	39	18	ecurrent	ecurrent	NOUN
ajbspi-37611	39	19	ovarian	ovarian	ADJ
ajbspi-37611	39	20	cancer	cancer	NOUN
ajbspi-37611	39	21	.	.	PUNCT
ajbspi-37611	40	1	siminal	siminal	ADJ
ajbspi-37611	40	2	oncol	oncol	ADJ
ajbspi-37611	40	3	34	34	NUM
ajbspi-37611	40	4	:	:	PUNCT
ajbspi-37611	40	5	s1	s1	NOUN
ajbspi-37611	40	6	-	-	PUNCT
ajbspi-37611	40	7	s15	s15	NOUN
ajbspi-37611	40	8	.	.	PUNCT
ajbspi-37611	41	1	2	2	X
ajbspi-37611	41	2	.	.	X
ajbspi-37611	41	3	ozols	ozol	NOUN
ajbspi-37611	41	4	rf	rf	X
ajbspi-37611	41	5	(	(	PUNCT
ajbspi-37611	41	6	2006	2006	NUM
ajbspi-37611	41	7	)	)	PUNCT
ajbspi-37611	41	8	challenges	challenge	NOUN
ajbspi-37611	41	9	of	of	ADP
ajbspi-37611	41	10	chemotherapyin	chemotherapyin	NOUN
ajbspi-37611	41	11	ovarian	ovarian	ADJ
ajbspi-37611	41	12	cancer	cancer	NOUN
ajbspi-37611	41	13	.	.	PUNCT
ajbspi-37611	42	1	ann	ann	PROPN
ajbspi-37611	42	2	oncol	oncol	PROPN
ajbspi-37611	42	3	17(suppl	17(suppl	NUM
ajbspi-37611	42	4	5	5	NUM
ajbspi-37611	42	5	):	):	PUNCT
ajbspi-37611	42	6	v181	v181	PROPN
ajbspi-37611	42	7	-	-	PUNCT
ajbspi-37611	42	8	v187	v187	PROPN
ajbspi-37611	42	9	.	.	PROPN
ajbspi-37611	43	1	3	3	NUM
ajbspi-37611	43	2	.	.	X
ajbspi-37611	43	3	zhang	zhang	PROPN
ajbspi-37611	43	4	l	l	PROPN
ajbspi-37611	43	5	,	,	PUNCT
ajbspi-37611	43	6	congo	congo	NOUN
ajbspi-37611	43	7	-	-	PUNCT
ajbspi-37611	43	8	garciajr	garciajr	NOUN
ajbspi-37611	43	9	,	,	PUNCT
ajbspi-37611	43	10	katsaros	katsaros	PROPN
ajbspi-37611	43	11	d	d	PROPN
ajbspi-37611	43	12	,	,	PUNCT
ajbspi-37611	43	13	gimutty	gimutty	PROPN
ajbspi-37611	43	14	pa	pa	PROPN
ajbspi-37611	43	15	,	,	PUNCT
ajbspi-37611	43	16	masssobro	masssobro	PROPN
ajbspi-37611	43	17	m	m	PROPN
ajbspi-37611	43	18	,	,	PUNCT
ajbspi-37611	43	19	et	et	PROPN
ajbspi-37611	43	20	al	al	PROPN
ajbspi-37611	43	21	(	(	PUNCT
ajbspi-37611	43	22	2003	2003	NUM
ajbspi-37611	43	23	)	)	PUNCT
ajbspi-37611	43	24	intratumoral	intratumoral	PROPN
ajbspi-37611	43	25	t	t	PROPN
ajbspi-37611	43	26	cell	cell	NOUN
ajbspi-37611	43	27	,	,	PUNCT
ajbspi-37611	43	28	recurrence	recurrence	NOUN
ajbspi-37611	43	29	and	and	CCONJ
ajbspi-37611	43	30	survivalin	survivalin	ADJ
ajbspi-37611	43	31	epithelial	epithelial	ADJ
ajbspi-37611	43	32	ovarian	ovarian	ADJ
ajbspi-37611	43	33	cancer	cancer	NOUN
ajbspi-37611	43	34	.	.	PUNCT
ajbspi-37611	44	1	n	n	PROPN
ajbspi-37611	44	2	engl	engl	PROPN
ajbspi-37611	44	3	j	j	PROPN
ajbspi-37611	44	4	med	med	PROPN
ajbspi-37611	44	5	348(3	348(3	NUM
ajbspi-37611	44	6	):	):	PUNCT
ajbspi-37611	44	7	203	203	NUM
ajbspi-37611	44	8	-	-	SYM
ajbspi-37611	44	9	213	213	NUM
ajbspi-37611	44	10	.	.	NOUN
ajbspi-37611	44	11	4	4	NUM
ajbspi-37611	44	12	.	.	X
ajbspi-37611	44	13	kempsi	kempsi	PROPN
ajbspi-37611	44	14	j	j	PROPN
ajbspi-37611	44	15	,	,	PUNCT
ajbspi-37611	44	16	karyamodi	karyamodi	PROPN
ajbspi-37611	44	17	l	l	PROPN
ajbspi-37611	44	18	,	,	PUNCT
ajbspi-37611	44	19	bohrens	bohrens	PROPN
ajbspi-37611	44	20	md	md	PROPN
ajbspi-37611	44	21	,	,	PUNCT
ajbspi-37611	44	22	erskine	erskine	PROPN
ajbspi-37611	44	23	cl	cl	PROPN
ajbspi-37611	44	24	,	,	PUNCT
ajbspi-37611	44	25	hartmannl	hartmannl	NOUN
ajbspi-37611	44	26	,	,	PUNCT
ajbspi-37611	44	27	et	et	PROPN
ajbspi-37611	44	28	al	al	PROPN
ajbspi-37611	44	29	.	.	PUNCT
ajbspi-37611	45	1	(	(	PUNCT
ajbspi-37611	45	2	2011	2011	NUM
ajbspi-37611	45	3	)	)	PUNCT
ajbspi-37611	45	4	tumor	tumor	NOUN
ajbspi-37611	45	5	infiltrating	infiltrate	VERB
ajbspi-37611	45	6	programmed	program	VERB
ajbspi-37611	45	7	deathreceptor1	deathreceptor1	PROPN
ajbspi-37611	45	8	-	-	PUNCT
ajbspi-37611	45	9	dendritic	dendritic	ADJ
ajbspi-37611	45	10	cellsmediate	cellsmediate	ADJ
ajbspi-37611	45	11	immune	immune	ADJ
ajbspi-37611	45	12	suppression	suppression	NOUN
ajbspi-37611	45	13	in	in	ADP
ajbspi-37611	45	14	ovarian	ovarian	ADJ
ajbspi-37611	45	15	cancer	cancer	NOUN
ajbspi-37611	45	16	.	.	PUNCT
ajbspi-37611	46	1	j	j	PROPN
ajbspi-37611	46	2	immunol	immunol	NOUN
ajbspi-37611	46	3	186(2	186(2	NUM
ajbspi-37611	46	4	):	):	PUNCT
ajbspi-37611	46	5	6905	6905	NUM
ajbspi-37611	46	6	-	-	SYM
ajbspi-37611	46	7	6913	6913	NUM
ajbspi-37611	46	8	.	.	PUNCT
ajbspi-37611	47	1	5	5	X
ajbspi-37611	47	2	.	.	X
ajbspi-37611	47	3	lhou	lhou	PROPN
ajbspi-37611	47	4	ic	ic	PROPN
ajbspi-37611	47	5	,	,	PUNCT
ajbspi-37611	47	6	ganesan	ganesan	PROPN
ajbspi-37611	47	7	p	p	PROPN
ajbspi-37611	47	8	,	,	PUNCT
ajbspi-37611	47	9	a	a	DET
ajbspi-37611	47	10	mstrong	mstrong	NOUN
ajbspi-37611	47	11	td	td	NOUN
ajbspi-37611	47	12	,	,	PUNCT
ajbspi-37611	47	13	jaffer	jaffer	PROPN
ajbspi-37611	47	14	em	em	PRON
ajbspi-37611	47	15	(	(	PUNCT
ajbspi-37611	47	16	2008	2008	NUM
ajbspi-37611	47	17	)	)	PUNCT
ajbspi-37611	47	18	effective	effective	ADJ
ajbspi-37611	47	19	depetion	depetion	NOUN
ajbspi-37611	47	20	of	of	ADP
ajbspi-37611	47	21	regulatory	regulatory	ADJ
ajbspi-37611	47	22	tcellsallows	tcellsallow	NOUN
ajbspi-37611	47	23	the	the	DET
ajbspi-37611	47	24	recruitment	recruitment	NOUN
ajbspi-37611	47	25	of	of	ADP
ajbspi-37611	47	26	mesothelin	mesothelin	NOUN
ajbspi-37611	47	27	-	-	PUNCT
ajbspi-37611	47	28	specific	specific	ADJ
ajbspi-37611	47	29	cd8+tcells	cd8+tcell	NOUN
ajbspi-37611	47	30	to	to	ADP
ajbspi-37611	47	31	the	the	DET
ajbspi-37611	47	32	antitumor	antitumor	PROPN
ajbspi-37611	47	33	response	response	NOUN
ajbspi-37611	47	34	against	against	ADP
ajbspi-37611	47	35	a	a	DET
ajbspi-37611	47	36	mensothelian	mensothelian	NOUN
ajbspi-37611	47	37	expressing	express	VERB
ajbspi-37611	47	38	mouse	mouse	NOUN
ajbspi-37611	47	39	pancreatic	pancreatic	ADJ
ajbspi-37611	47	40	adenocarcinoma	adenocarcinoma	NOUN
ajbspi-37611	47	41	.	.	PUNCT
ajbspi-37611	48	1	clin	clin	PROPN
ajbspi-37611	48	2	transl	transl	PROPN
ajbspi-37611	48	3	sci	sci	PROPN
ajbspi-37611	48	4	1(3	1(3	NUM
ajbspi-37611	48	5	):	):	PUNCT
ajbspi-37611	48	6	28	28	NUM
ajbspi-37611	48	7	-	-	SYM
ajbspi-37611	48	8	39	39	NUM
ajbspi-37611	48	9	.	.	PUNCT
ajbspi-37611	49	1	6	6	NUM
ajbspi-37611	49	2	.	.	PUNCT
ajbspi-37611	50	1	wang	wang	PROPN
ajbspi-37611	50	2	b	b	PROPN
ajbspi-37611	50	3	,	,	PUNCT
ajbspi-37611	50	4	kurowa	kurowa	PROPN
ajbspi-37611	50	5	jm	jm	PROPN
ajbspi-37611	50	6	,	,	PUNCT
ajbspi-37611	50	7	helz	helz	NOUN
ajbspi-37611	50	8	,	,	PUNCT
ajbspi-37611	50	9	charalambous	charalambous	ADJ
ajbspi-37611	50	10	a	a	PRON
ajbspi-37611	50	11	,	,	PUNCT
ajbspi-37611	50	12	keler	keler	NOUN
ajbspi-37611	50	13	t	t	PROPN
ajbspi-37611	50	14	,	,	PUNCT
ajbspi-37611	50	15	et	et	PROPN
ajbspi-37611	50	16	al	al	PROPN
ajbspi-37611	50	17	.	.	PROPN
ajbspi-37611	51	1	(	(	PUNCT
ajbspi-37611	51	2	2009	2009	NUM
ajbspi-37611	51	3	)	)	PUNCT
ajbspi-37611	51	4	the	the	DET
ajbspi-37611	51	5	human	human	PROPN
ajbspi-37611	51	6	cancerantigen	cancerantigen	PROPN
ajbspi-37611	51	7	mesothelin	mesothelin	PROPN
ajbspi-37611	51	8	is	be	AUX
ajbspi-37611	51	9	more	more	ADV
ajbspi-37611	51	10	efficiently	efficiently	ADV
ajbspi-37611	51	11	presented	present	VERB
ajbspi-37611	51	12	to	to	ADP
ajbspi-37611	51	13	the	the	DET
ajbspi-37611	51	14	mouse	mouse	NOUN
ajbspi-37611	51	15	immune	immune	ADJ
ajbspi-37611	51	16	system	system	NOUN
ajbspi-37611	51	17	when	when	SCONJ
ajbspi-37611	51	18	targeted	target	VERB
ajbspi-37611	51	19	to	to	ADP
ajbspi-37611	51	20	the	the	DET
ajbspi-37611	51	21	dec205	dec205	PROPN
ajbspi-37611	51	22	/	/	SYM
ajbspi-37611	51	23	cd205	cd205	NOUN
ajbspi-37611	51	24	receptor	receptor	NOUN
ajbspi-37611	51	25	on	on	ADP
ajbspi-37611	51	26	dendritic	dendritic	ADJ
ajbspi-37611	51	27	cells	cell	NOUN
ajbspi-37611	51	28	.	.	PUNCT
ajbspi-37611	52	1	ann	ann	PROPN
ajbspi-37611	52	2	ny	ny	PROPN
ajbspi-37611	52	3	acad	acad	PROPN
ajbspi-37611	52	4	sci	sci	PROPN
ajbspi-37611	52	5	174	174	NUM
ajbspi-37611	52	6	:	:	PUNCT
ajbspi-37611	52	7	6	6	NUM
ajbspi-37611	52	8	-	-	SYM
ajbspi-37611	52	9	17	17	NUM
ajbspi-37611	52	10	.	.	PUNCT
ajbspi-37611	53	1	7	7	X
ajbspi-37611	53	2	.	.	X
ajbspi-37611	53	3	kan	kan	PROPN
ajbspi-37611	53	4	me	me	PROPN
ajbspi-37611	53	5	,	,	PUNCT
ajbspi-37611	53	6	butte	butte	PROPN
ajbspi-37611	53	7	mj	mj	PROPN
ajbspi-37611	53	8	,	,	PUNCT
ajbspi-37611	53	9	freeman	freeman	PROPN
ajbspi-37611	53	10	gj	gj	PROPN
ajbspi-37611	53	11	,	,	PUNCT
ajbspi-37611	53	12	sharpe	sharpe	PROPN
ajbspi-37611	53	13	ah	ah	INTJ
ajbspi-37611	53	14	(	(	PUNCT
ajbspi-37611	53	15	2008	2008	NUM
ajbspi-37611	53	16	)	)	PUNCT
ajbspi-37611	53	17	pd1and	pd1and	NOUN
ajbspi-37611	53	18	its	its	PRON
ajbspi-37611	53	19	ligand	ligand	NOUN
ajbspi-37611	53	20	in	in	ADP
ajbspi-37611	53	21	cancer	cancer	NOUN
ajbspi-37611	53	22	and	and	CCONJ
ajbspi-37611	53	23	immunity	immunity	NOUN
ajbspi-37611	53	24	.	.	PUNCT
ajbspi-37611	54	1	ann	ann	PROPN
ajbspi-37611	54	2	rev	rev	PROPN
ajbspi-37611	54	3	immunol	immunol	PROPN
ajbspi-37611	54	4	26(5	26(5	PROPN
ajbspi-37611	54	5	):	):	PUNCT
ajbspi-37611	54	6	677	677	NUM
ajbspi-37611	54	7	-	-	SYM
ajbspi-37611	54	8	704	704	NUM
ajbspi-37611	54	9	.	.	PUNCT
ajbspi-37611	55	1	8	8	NUM
ajbspi-37611	55	2	.	.	X
ajbspi-37611	55	3	freeman	freeman	PROPN
ajbspi-37611	55	4	gj	gj	PROPN
ajbspi-37611	55	5	,	,	PUNCT
ajbspi-37611	55	6	wherry	wherry	PROPN
ajbspi-37611	55	7	ej	ej	PROPN
ajbspi-37611	55	8	,	,	PUNCT
ajbspi-37611	55	9	ahmed	ahmed	PROPN
ajbspi-37611	55	10	r	r	PROPN
ajbspi-37611	55	11	,	,	PUNCT
ajbspi-37611	55	12	sharpe	sharpe	PROPN
ajbspi-37611	55	13	ah	ah	INTJ
ajbspi-37611	55	14	(	(	PUNCT
ajbspi-37611	55	15	2006	2006	NUM
ajbspi-37611	55	16	)	)	PUNCT
ajbspi-37611	55	17	reinvigorating	reinvigorate	VERB
ajbspi-37611	55	18	exhaustivre	exhaustivre	PROPN
ajbspi-37611	55	19	hiv	hiv	PROPN
ajbspi-37611	55	20	specific	specific	ADJ
ajbspi-37611	55	21	tcells	tcell	NOUN
ajbspi-37611	55	22	via	via	ADP
ajbspi-37611	55	23	pd1	pd1	NOUN
ajbspi-37611	55	24	-	-	PUNCT
ajbspi-37611	55	25	pdl1	pdl1	NOUN
ajbspi-37611	55	26	blockade	blockade	NOUN
ajbspi-37611	55	27	.	.	PUNCT
ajbspi-37611	56	1	j	j	PROPN
ajbspi-37611	56	2	exp	exp	NOUN
ajbspi-37611	56	3	med	med	PROPN
ajbspi-37611	56	4	203(10	203(10	NUM
ajbspi-37611	56	5	):	):	PUNCT
ajbspi-37611	56	6	2223	2223	NUM
ajbspi-37611	56	7	-	-	SYM
ajbspi-37611	56	8	2227	2227	NUM
ajbspi-37611	56	9	.	.	PUNCT
ajbspi-37611	57	1	9	9	X
ajbspi-37611	57	2	.	.	X
ajbspi-37611	57	3	wilke	wilke	PROPN
ajbspi-37611	57	4	cm	cm	PROPN
ajbspi-37611	57	5	,	,	PUNCT
ajbspi-37611	57	6	kryczek	kryczek	NOUN
ajbspi-37611	57	7	c	c	NOUN
ajbspi-37611	57	8	,	,	PUNCT
ajbspi-37611	57	9	zhou	zhou	PROPN
ajbspi-37611	57	10	w	w	PROPN
ajbspi-37611	57	11	(	(	PUNCT
ajbspi-37611	57	12	2011	2011	NUM
ajbspi-37611	57	13	)	)	PUNCT
ajbspi-37611	57	14	antigen	antigen	NOUN
ajbspi-37611	57	15	presenting	present	VERB
ajbspi-37611	57	16	cells	cell	NOUN
ajbspi-37611	57	17	(	(	PUNCT
ajbspi-37611	57	18	apc	apc	PROPN
ajbspi-37611	57	19	)	)	PUNCT
ajbspi-37611	57	20	subsetsin	subsetsin	PROPN
ajbspi-37611	57	21	ovarian	ovarian	ADJ
ajbspi-37611	57	22	cancer	cancer	NOUN
ajbspi-37611	57	23	.	.	PUNCT
ajbspi-37611	58	1	int	int	PROPN
ajbspi-37611	58	2	rev	rev	VERB
ajbspi-37611	58	3	immunol	immunol	NOUN
ajbspi-37611	58	4	30(2	30(2	PROPN
ajbspi-37611	58	5	-	-	SYM
ajbspi-37611	58	6	3	3	NUM
ajbspi-37611	58	7	):	):	PUNCT
ajbspi-37611	58	8	120	120	NUM
ajbspi-37611	58	9	-	-	SYM
ajbspi-37611	58	10	126	126	NUM
ajbspi-37611	58	11	.	.	PUNCT
ajbspi-37611	59	1	10	10	NUM
ajbspi-37611	59	2	.	.	PUNCT
ajbspi-37611	60	1	nolon	nolon	PROPN
ajbspi-37611	60	2	b	b	PROPN
ajbspi-37611	60	3	,	,	PUNCT
ajbspi-37611	60	4	opel	opel	PROPN
ajbspi-37611	60	5	s	s	PROPN
ajbspi-37611	60	6	,	,	PUNCT
ajbspi-37611	60	7	del	del	PROPN
ajbspi-37611	60	8	-	-	ADJ
ajbspi-37611	60	9	pozzo	pozzo	ADJ
ajbspi-37611	60	10	f	f	NOUN
ajbspi-37611	60	11	,	,	PUNCT
ajbspi-37611	60	12	soldon	soldon	VERB
ajbspi-37611	60	13	c	c	NOUN
ajbspi-37611	60	14	,	,	PUNCT
ajbspi-37611	60	15	zilo	zilo	PROPN
ajbspi-37611	60	16	s	s	PROPN
ajbspi-37611	60	17	,	,	PUNCT
ajbspi-37611	60	18	et	et	PROPN
ajbspi-37611	60	19	al	al	PROPN
ajbspi-37611	60	20	.	.	PUNCT
ajbspi-37611	61	1	(	(	PUNCT
ajbspi-37611	61	2	2011	2011	NUM
ajbspi-37611	61	3	)	)	PUNCT
ajbspi-37611	61	4	chemokine	chemokine	ADJ
ajbspi-37611	61	5	nitration	nitration	NOUN
ajbspi-37611	61	6	prevents	prevent	VERB
ajbspi-37611	61	7	intratumoral	intratumoral	ADJ
ajbspi-37611	61	8	https://doi.org/10.37547/ajbspi/volume03issue03-01	https://doi.org/10.37547/ajbspi/volume03issue03-01	PROPN
ajbspi-37611	61	9	https://scholar.google.co.in/scholar?q=	https://scholar.google.co.in/scholar?q=	AUX
ajbspi-37611	61	10	https://www.mendeley.com/search/?page=1&query=	https://www.mendeley.com/search/?page=1&query=	ADJ
ajbspi-37611	61	11	volume	volume	NOUN
ajbspi-37611	61	12	03	03	NUM
ajbspi-37611	61	13	issue	issue	NOUN
ajbspi-37611	61	14	10	10	NUM
ajbspi-37611	61	15	-	-	SYM
ajbspi-37611	61	16	2023	2023	NUM
ajbspi-37611	61	17	5	5	NUM
ajbspi-37611	61	18	american	american	ADJ
ajbspi-37611	61	19	journal	journal	PROPN
ajbspi-37611	61	20	of	of	ADP
ajbspi-37611	61	21	biomedical	biomedical	PROPN
ajbspi-37611	61	22	science	science	PROPN
ajbspi-37611	61	23	&	&	CCONJ
ajbspi-37611	61	24	pharmaceutical	pharmaceutical	PROPN
ajbspi-37611	61	25	innovation	innovation	NOUN
ajbspi-37611	61	26	(	(	PUNCT
ajbspi-37611	61	27	issn	issn	PROPN
ajbspi-37611	61	28	–	–	PUNCT
ajbspi-37611	61	29	2771	2771	NUM
ajbspi-37611	61	30	-	-	SYM
ajbspi-37611	61	31	2753	2753	NUM
ajbspi-37611	61	32	)	)	PUNCT
ajbspi-37611	61	33	volume	volume	NOUN
ajbspi-37611	61	34	03	03	NUM
ajbspi-37611	61	35	issue	issue	NOUN
ajbspi-37611	61	36	10	10	NUM
ajbspi-37611	61	37	pages	page	NOUN
ajbspi-37611	61	38	:	:	PUNCT
ajbspi-37611	61	39	1	1	NUM
ajbspi-37611	61	40	-	-	SYM
ajbspi-37611	61	41	5	5	NUM
ajbspi-37611	61	42	sjif	sjif	NOUN
ajbspi-37611	61	43	impact	impact	NOUN
ajbspi-37611	61	44	factor	factor	NOUN
ajbspi-37611	61	45	(	(	PUNCT
ajbspi-37611	61	46	2021	2021	NUM
ajbspi-37611	61	47	:	:	PUNCT
ajbspi-37611	61	48	5	5	NUM
ajbspi-37611	61	49	.	.	NOUN
ajbspi-37611	61	50	705	705	NUM
ajbspi-37611	61	51	)	)	PUNCT
ajbspi-37611	61	52	(	(	PUNCT
ajbspi-37611	61	53	2022	2022	NUM
ajbspi-37611	61	54	:	:	PUNCT
ajbspi-37611	61	55	5	5	NUM
ajbspi-37611	61	56	.	.	NOUN
ajbspi-37611	61	57	705	705	NUM
ajbspi-37611	61	58	)	)	PUNCT
ajbspi-37611	61	59	(	(	PUNCT
ajbspi-37611	61	60	2023	2023	NUM
ajbspi-37611	61	61	:	:	PUNCT
ajbspi-37611	62	1	6.534	6.534	NUM
ajbspi-37611	62	2	)	)	PUNCT
ajbspi-37611	62	3	oclc	oclc	PROPN
ajbspi-37611	62	4	–	–	PUNCT
ajbspi-37611	62	5	1121105677	1121105677	NUM
ajbspi-37611	62	6	publisher	publisher	NOUN
ajbspi-37611	62	7	:	:	PUNCT
ajbspi-37611	62	8	oscar	oscar	NOUN
ajbspi-37611	62	9	publishing	publishing	NOUN
ajbspi-37611	62	10	services	service	NOUN
ajbspi-37611	62	11	servi	servi	ADJ
ajbspi-37611	62	12	infiltration	infiltration	NOUN
ajbspi-37611	62	13	of	of	ADP
ajbspi-37611	62	14	antigen	antigen	ADJ
ajbspi-37611	62	15	specific	specific	ADJ
ajbspi-37611	62	16	t	t	NOUN
ajbspi-37611	62	17	cells	cell	NOUN
ajbspi-37611	62	18	.	.	PUNCT
ajbspi-37611	63	1	j	j	PROPN
ajbspi-37611	63	2	exp	exp	NOUN
ajbspi-37611	63	3	med	med	PROPN
ajbspi-37611	63	4	208(10	208(10	NUM
ajbspi-37611	63	5	):	):	PUNCT
ajbspi-37611	63	6	1949	1949	NUM
ajbspi-37611	63	7	-	-	SYM
ajbspi-37611	63	8	1962	1962	NUM
ajbspi-37611	63	9	.	.	PUNCT
ajbspi-37611	64	1	https://doi.org/10.37547/ajbspi/volume03issue03-01	https://doi.org/10.37547/ajbspi/volume03issue03-01	PROPN
ajbspi-37611	64	2	https://scholar.google.co.in/scholar?q=	https://scholar.google.co.in/scholar?q=	PROPN
ajbspi-37611	64	3	https://www.mendeley.com/search/?page=1&query=	https://www.mendeley.com/search/?page=1&query=	NOUN